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Abstract 
 
Background 
Obesity and chronic low back pain (cLBP) are prevalent social and economic burdens with significant 
contribution to poor overall health. Previous research has viewed the two health conditions as 
separate research and clinical problems, but there is evidence of a relationship between them. 
However, combined obesity and cLBP research is limited and not well understood. 
 
Aim 
The aim of this thesis was to investigate the relationship between obesity and cLBP, and to explore 
the possible factors mediating that relationship.  
 
Methods 
A series of three explorative studies were employed to examine the relationship between obesity and 
cLBP. Study 1 investigated associations between BMI and exercise-related cLBP changes. Study 2 was 
an exploration of associations between adipose tissue distribution and cLBP. Study 3 investigated the 
effect of body mass distribution on a known postural task, and the possible mediation by movement 
of the lumbar spine or lumbar muscle endurance. 
 
Results 
BMI and BMI changes were not associated with cLBP, or successful predictors of cLBP changes. 
Regional adiposity, particularly the ratio of abdominal to lumbar adiposity, was associated with and 
xii 
 
a significant predictor of cLBP. Body mass distribution was shown to result in poorer postural task 
performance, but mediation by spinal movement or muscle endurance was not confirmed. 
 
Discussion 
No significant relationships between BMI and cLBP were identified, indicating the reliance on BMI as 
an obesity measure may not be justified. The established associations between regional adiposity 
distribution and cLBP may suggest that adipose tissue is a key contributor within the obesity-cLBP 
relationship. Although mediation of spinal movement or muscle endurance was not supported in the 
experimental context used, the link between body composition and mass distribution with cLBP was 
further confirmed.  
 
Conclusion 
The work of this thesis supports evidence of a link between obesity and cLBP. Adiposity and body 
mass distribution have been implicated in this relationship. Future studies should continue to explore 
possible mediating factors between obesity and cLBP in a variety of research contexts.     
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Chapter 1: Introduction  
 
1.1 The Problem 
 
Obesity and chronic low back pain (cLBP) are both common and disabling health conditions.1 Obesity 
refers to a state of increased fatness contributing to metabolic dysfunction.2 The commonly accepted 
classification for obesity is a body mass index (BMI) ≥30.0kg/m2, or waist circumference (WC) ≥88cm 
or ≥102cm for abdominal obesity in women and men respectively.3 cLBP is the presence of low back 
pain (LBP; pain below the costal margin and above the gluteal fold) for a minimum of 12 consecutive 
weeks.4 Both conditions contribute significant costs to society. The social and financial burden of 
obesity and cLBP can be attributed to expenses associated with healthcare of obesity-related chronic 
diseases, and costs incurred by various cLBP treatments.1, 5-13  
 
The prevalence of obesity is on the rise, causing the condition to be labelled as an epidemic.3, 14 Since 
the morbidity and mortality associated with obesity continues to increase, it has become a serious 
public health concern.15 For example, cross-sectional studies have revealed that obesity in the United 
States accounted for 35.7% of the population in 2009-2010,16 compared to 30.5% ten years earlier.17 
Obesity is also a prevalent condition in Australia, with 20-25% of the population reported as obese in 
1999-2000.18 Moreover, in a 2017 study modelling trends of the Australian adult population, obesity 
was projected to increase from 19.5% in 1995 to 35% by the year 2025.19 Obesity rates in Australia 
have already tripled in the previous three decades (1980-2008),20 with 1 in 4 of the population now 
classified as obese.20 More importantly, obesity is a global health problem, with 12% of adults 
reported as obese globally.21 If the post-2000 trends continue, the prevalence of global obesity has 
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been estimated to rise to 18% by the year 2025.22 On average, the world’s population is said to 
become >1.5kg heavier per decade.22 In an age-standardised analysis of adult obesity from 1975 to 
2014, the global obesity prevalence was found to have increased from 3.2% to 10.8%, and 6.4% to 
14.9% in men and women respectively.22 However, not only is it prevalent, but obesity is also a costly 
condition.23 Total direct obesity costs in Australia have been previously estimated to equal $8.3 billion 
annually, which rose to $18.8 billion when overweight was also considered.24 The health expenditure 
of individuals has recently been shown to coincide with obesity occurrence, whereby obese 
individuals exhibit approximately 30% higher expenditure than those of a normal weight.20   
 
Obesity is considered to be the number one preventable public health concern in the United States.2 
For example, due to the risks and accelerating effect that obesity has on the metabolic syndrome and 
cancer, obesity may become detrimental to society if prevention and treatment are not carefully 
considered.2 Many of the costs incurred by obesity are the result of complications of the condition 
and the comorbidities associated with it. Such problems can be attributed to the release of pro-
inflammatory adipokines, in addition to the physical burden of additional body weight from excess 
adiposity.2 For instance, adipose tissue affects the body via the space it occupies within and around 
bodily organs and structures.2 Complications of obesity can include hypertension, endothelial 
dysfunction, cardiovascular disease, impaired glucose tolerance and type 2 diabetes mellitus.15 
Moreover, obesity can result in or put individuals at greater risk of comorbidities. These may include 
degenerative joint disease, obstructive sleep apnoea, increased pulmonary embolism, gallstone 
disease and gallbladder cancer, polycystic ovarian syndrome, preeclampsia and renal failure.2 There 
are also gender-specific adverse effects of obesity, such as the possibility of amenorrhea, infertility, 
pregnancy complications and urinary stress incontinence in women.2 Furthermore, obesity has been 
linked to emotional disorders, such as depression and bipolar disorder.15 More importantly, obesity 
has been suggested to exist simultaneously to a number of chronic pain conditions.25 
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LBP is also prevalent, since it affects 10% of the world’s population and has been recently ranked as 
the 7th leading disability in the world.26 It is also the highest ranking disability in regards to the number 
of years lived with the condition.26 Research indicates that approximately 80% of a given population 
will experience LBP at some point in their life.1 Moreover, the majority of people that experience 
activity-limiting LBP will also suffer from recurrent episodes.10 While most people recover from an 
episode, for a portion of the population LBP episodes become chronic.1 The impact of LBP on health 
care systems in western society arises from the chronicity of the condition. cLBP is a common health 
problem in the western world, with 10.2% of people affected by the condition, regardless of gender, 
age or race.1 cLBP is also on the rise, with a survey of the United States population observing a 162% 
increase in the condition from 1992 to 2006.1 cLBP places a large economic burden on society, due to 
work absenteeism and treatment-related expenses.10, 13 Such cLBP treatments include physiotherapy, 
chiropractic, massage, prescribed and over-the-counter drugs, osteopathy, acupuncture, psychology, 
naturopathy and occupational therapy.13 The socioeconomic burden of the condition is so 
pronounced that there is said to be “general pessimism surrounding the prognosis of cLBP.”27 For 
example, in a systematic review of the costs associated with LBP, the indirect cost of lost work 
productivity was the greatest overall expense.27 In Australia specifically, loss of income and treatment 
costs associated with cLBP are estimated to be $9.17 billion dollars annually.13 
 
Past research on obesity and pain have been two entirely separate fields of study. For example, 
previous studies on obesity have investigated a variety of topics. These include the effect of diet and 
exercise,28-31 obesity epidemiology and physiology,2, 18 measurements of obesity,3, 14, 32-36 and 
relationships to other health conditions such as diabetes and insulin resistance,37, 38 bone density 
reduction,39 sleep disturbance40 and cancer.41  In contrast, much of the previous back pain research 
was generalised to LBP and commonly focused on factors such as neuromuscular control,42-56 
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psychosocial factors57-60 and the most effective treatment type.51, 61-66 However, in more recent years 
the two separate fields of research of obesity and pain conditions have been merged together. This 
research crossover is significant because of the finding that people in chronic pain are often obese,67 
and those who are obese are often in pain.14 68 For example, obese individuals have been found to be 
at a greater risk of pain induced by headaches.69 As a result, there have been suggestions of common 
physiological pathways underpinning both obesity and pain conditions.67, 70 More importantly, there 
is evidence of a specific relationship between obesity and cLBP23, 71-80 that warrants further 
exploration.  
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1.2 The Content and Context of this Thesis 
 
The obesity-cLBP relationship has commonly been evidenced via an association between BMI, a 
measurement commonly used to indicate overweight and obesity,3, 14 and cLBP.23, 81 However, it is 
unknown if obesity is a true causal factor,75, 77 or rather indirectly contributes to cLBP.67, 70 It may be 
possible for obesity to exacerbate or prolong existing cLBP, through the provocation and persistence 
of pain symptoms. This thesis aimed to investigate the relationship between obesity and cLBP by 
initially confirming an association between the two conditions, and thereafter to explore possible 
factors mediating that association.  
 
Obesity was examined as more than a basic condition of body mass or simplistic measurements such 
as BMI, but rather a problem of adipose tissue and its impact on the body. Furthermore, this thesis 
discusses oversights of past research, particularly the previously unconsidered body mass 
distribution. Therefore, this research looked to investigate the mediating factors between obesity 
and cLBP, including adiposity and mass distribution. It also considered the effect of adiposity on 
postural task performance in cLBP individuals. Collectively, these themes will bring about an 
enhanced understanding of the relationship between these two disabling and costly health 
conditions, and what it may signify for future research and treatment possibilities. 
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1.3 Thesis Overview 
 
Figure 1.1 illustrates the outline of experimental studies conducted within this thesis, for the purpose 
of fulfilling the primary aim to investigate the relationship between obesity and cLBP.  
 
 
 
Figure 1.1 Outline of experimental studies contained within this thesis 
 
 
1.3.1 Study 1: Examining relationships between body mass index and chronic low back 
pain before and after exercise 
 
Since a relationship between obesity and cLBP has been previously suggested,6, 23, 78 there is a 
rationale for this relationship to be further explored. In past studies, the emphasis has been on the 
use of BMI as a measurement of obesity in cLBP research.23, 81 However, no studies have examined 
the relationship between BMI and cLBP prior to and immediately following an exercise intervention. 
Such research is important, as exercise is a commonly prescribed treatment for those suffering from 
cLBP.82-86 Therefore, the first objective of this thesis was to investigate the relationship between BMI 
and changes in pain and disability levels among cLBP participants following an exercise program. 
Study 1: BMI and cLBP
• Investigating the 
relationship between 
BMI and cLBP before 
and after exercise 
treatment for cLBP
Study 2: Adiposity and 
cLBP
• Exploring possible 
associations between 
total body and 
regional adiposity 
with cLBP 
Study 3: Body mass and 
task performance in 
cLBP
• Examining 
associations and 
possible mediators 
between body mass 
distribution and 
postural task 
performance in cLBP 
individuals
7 
 
1.3.2 Study 2: Investigating associations between adiposity and chronic low back pain 
 
Despite its frequent use, the BMI measurement has been previously criticised for its inability to 
discriminate between fat and fat-free mass within the body.73, 80 Such limitations of BMI are important 
to consider regarding the obesity-cLBP relationship, since higher levels of adiposity (fat mass) have 
been linked to pain.80 Furthermore, centrally-located visceral adiposity has been associated with pain 
conditions such as fibromyalgia (FM),87 in addition to other medical pathologies88 and obesity-related 
disorders.89, 90 Consequently, simplistic weight indices such as BMI may be surpassed by adiposity-
specific obesity measurements. Moreover, there is a lack of research on the potential links between 
adiposity and its bodily distribution with cLBP. There are various possible factors that may mediate a 
relationship between adiposity and cLBP. Such explanatory variables may include adiposity-
stimulated inflammation,80, 91-93 or the increased mechanical load on the spine.80, 94 While it may 
plausible for adiposity distribution to be associated with cLBP, research into this relationship and its 
possible mediators is currently lacking. However, before investigation into obesity-cLBP mediation 
can be pursued, associations between adipose tissue and cLBP must first be confirmed. Therefore, 
the second objective of this thesis was to explore the relationship between total body and regional 
adiposity with cLBP, using alternative measurements to BMI. 
 
1.3.3 Study 3: Exploring the effect of body mass distribution on task performance in the 
obesity-chronic low back pain relationship 
 
It is also reasonable to believe that obesity (particularly abdominal adiposity) may have an effect on 
pain development and postural task performance. For example, perhaps increased abdominal mass 
may induce back pain through greater gravitational pull on the lumbar spine, as a result of spinal 
movement. This acute lumbar flexion may then promote excessive activation of spinal extensor 
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muscles to maintain balance, and consequently increase tissue strain on the lumbar spine region.95 
Furthermore, the task-specific lumbar flexion and increased muscle activation may result in a faster 
rate of lumbar muscle fatigue. Since increased lumbar flexion is known to coincide with LBP,94 it is 
possible that greater abdominal mass may heighten pain experienced in a postural task. However, 
this notion is yet to be explored. Therefore, the third objective of this thesis was to explore the effect 
of body mass distribution on pain development, muscle fatigue and spinal movement in a postural 
task.   
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1.4 Summary 
 
Past research on obesity and pain conditions has provided evidence of a relationship between obesity 
and cLBP. However, the nature and potential mechanisms of this relationship are yet to be 
determined. It is currently unknown if BMI is related to changes in cLBP following exercise, if adipose 
tissue distribution is related to cLBP, and if mass distribution has an effect on pain and task 
performance in cLBP individuals. Therefore, this thesis aims to confirm a relationship between obesity 
and cLBP, and investigate possible contributing factors to the relationship.   
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1.5 Experimental Objectives and Hypotheses 
 
1.5.1 Thesis objectives 
• To investigate associations between BMI and changes in pain and disability levels among cLBP 
participants following an exercise program. 
• To assess associations between total body and regional adiposity and cLBP using alternative 
methods to BMI. 
• To examine associations and mediating factors between body mass distribution and postural 
task performance in people with cLBP.  
 
1.5.2 Thesis hypotheses 
• Greater abdominal adiposity, particularly visceral, will be associated with increased self-
reported pain and disability in cLBP individuals.  
• cLBP individuals with greater abdominal adiposity will exhibit greater spinal movement, a 
faster rate of lumbar muscle fatigue, and acute flexion-induced pain development during a 
postural task.  
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1.6 Significance and Originality of the Research 
 
Both obesity and cLBP are disabling conditions, with significant costs to the lives of individuals and 
society as a whole. Obesity is a known contributor to pathophysiological and metabolic disorders, 
and may exacerbate existing medical conditions. Similarly, cLBP is a social and financial burden to the 
western world. It is a common chronic health condition, affecting numerous countries worldwide and 
is a major cause of work absenteeism. 
 
Not only is the link between obesity and pain still relatively recent, but there has been minimal 
combined research on obesity and cLBP. Moreover, previous research lacks consideration of body 
mass distribution in the obesity-cLBP relationship. It is possible that body mass distribution is a crucial 
factor previously overlooked in cLBP research, which may help explain why after 20 years of research 
the etiology of cLBP still remains unknown.  
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Chapter 2: Literature Review 
 
2.1 Background 
 
2.1.1 Physiology of obesity 
 
Obesity is characterised by excess adipose tissue contributing to the dysregulation and dysfunction 
of the body and its associated components.2 The excessive storage of fat as adipose tissue results in 
the release of free fatty acids,96 causing lipotoxicity in both adipose and non-adipose tissues alike.2 
For this reason, obesity is often involved in the pathophysiology of organ dysfunction (including the 
liver and pancreas) and is known to contribute to the metabolic syndrome.2, 25, 96, 97 Furthermore, the 
release of free fatty acids also results in the dysregulation of glucose metabolism causing insulin 
resistance from insulin receptor dysfunction.2, 96 Consequently, this promotes the production of 
further glucose, causing hyperglycaemia and creating a cycle of dysfunctional insulin and glucose 
production and metabolism.2 The adverse impact on normal glucose and lipid metabolism brought 
about by the positive energy balance of excess adipose tissue is a known contributor to the insulin 
resistant state embodying type 2 diabetes mellitus.2, 15, 18, 98  
 
Due to the rise in obesity, the focus on and importance of adiposity has increased.15 The normal 
function of adipocytes (fat cells) is the synchronised management of triglyceride synthesis 
(lipogenesis) and storage, with its rate of breakdown (lipolysis).15 The way in which obesity impacts 
normal lipid and glucose regulation is via the secretion of large amounts of adipocyte-produced 
cytokines, or adipokines (proteins produced from fat cells).2, 96, 97 These cytokines are known to 
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contribute to vascular dysfunction, atherosclerosis and inflammation.2 In a holistic context, this 
disordered metabolic state causes organs and body systems to dysfunction, worsens the metabolic 
syndrome and accelerates cancer conditions.2 As a result, the comorbidities to obesity are numerous, 
particularly through the effect obesity has on the normal functioning of organs and body systems.2 
Such systems include the liver, and cardiac, pulmonary, endocrine, immune and reproductive 
systems.2 
 
2.1.2 Physiology of pain 
 
Pain is an unpleasant sensory and emotional experience that is highly subjective and is associated 
with actual or potential tissue damage to the body.92, 99, 100 In most cases the pain experience process 
begins in the body’s periphery, where nociceptors detect noxious stimuli and transmit the pain signal 
to the brain via the spinal cord.99-101 This stimulation of peripheral nociceptive receptors, termed 
primary sensitisation, results in the release of magnesium ions and subsequent activation of N-
methyl-D-aspartate (NMDA) receptors, causing expansion of the pain receptive field and lowering of 
the depolarisation threshold.92 It is possible for the repetition of this peripheral response to pain to 
occur, which may be through a continual pain-provoking stimulus or an increased intensity of painful 
stimuli.92, 99 In such instances hyperalgesia follows, which is the increased pain response to an already 
painful stimulus.92 The repetition of the primary pain response and continual nociceptive afferent 
barrage to the spinal cord then leads to central (secondary) sensitisation.92 Consequently, the 
receptive field of NMDA receptors is further expanded, and a progressive accumulation of the overall 
pain response takes place in the dorsal horn neurons of the spinal cord.92 Since each neuron can 
synapse with several thousand additional neurons, the level of pain is further amplified.92 Therefore, 
the end result of repeated central sensitisation is the maladaptive chronicity of pain,92, 99 which often 
displays the characteristics of a disease by its debilitating and unrelenting nature.100 
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2.2 The Beginning: A Link Between Obesity and Pain 
 
There is a growing body of evidence to suggest a relationship between obesity and pain.67 For 
example, the presence of pain is a highly prevalent complaint to healthcare providers,14, 67 whereby 
50% of obese patients seeking treatment also report a moderate to severe level of pain.14 68 Previous 
research has identified a consistent linear relationship between increasing obesity and the reporting 
of pain.70 In a study on individuals in the general population, it was found that the trend between 
obesity and pain became more apparent at each level of obesity (class I, II and III), whereby individuals 
at higher levels of obesity were more likely to report pain in increasing numbers of locations around 
the body.70 In particular, pain complaints were more common with increasing BMI.67 Research into 
obesity and pain conditions is not a new area of study, but is increasing in popularity since both 
obesity and chronic pain are on the rise.68 Research has shown that obesity is a common comorbidity 
to conditions of chronic pain,67 and that people who are overweight or obese are more susceptible 
to an increased occurrence of chronic pain conditions. Moreover, linear trends between BMI and 
chronic pain have also been shown, with up to a 254% greater rate of recurrent pain among those 
with morbid obesity (BMI≥40) compared to people of normal weight.67 A recent review by Okifuji and 
Hare (2015) highlighted the commonality of obesity among chronic pain sufferers of varying nature, 
including widespread pain, FM and osteoarthritis (OA).67 Within these chronic pain populations, 
several indicators of overweight or obesity have been linked to pain, including BMI, fat mass and 
waist circumference.67 Obesity was also a proposed risk factor for future pain presence and 
persistence of arm, low back and widespread pain.67 To further compound the problem, chronic pain 
was a frequently reported reason for increases in weight.67 Several pain conditions have been 
explored in the context of a relationship to obesity.  
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Significant associations between obesity and pain conditions have been identified and supported by 
past research, including headache or migraine,23, 69, 102-106 back pain,23, 70-74, 76, 78-80, 106-113 chronic pain,23, 
110, 114-117 neck or shoulder pain,70, 78, 110 abdominal pain,23, 106 lower extremity pain,70, 106 FM,23, 118-123 
OA117, 124-131 and rheumatoid arthritis (RA).132-137 Obesity is also a known or potential risk factor for 
future development of certain pain conditions, such as LBP,14 OA,14, 68 FM68 and RA.68 In a twin-based 
study, it was found that overweight and obese twins were 1.3 to 3.0 times more likely than those of 
a normal weight to report pain diagnoses and symptoms, including LBP, headache or migraine, FM, 
abdominal pain and chronic widespread pain.23 Among adults, LBP, FM and arthritis are the most 
commonly suffered chronic pain conditions,68 with OA and LBP being the most frequently researched 
conditions of co-occurrence to obesity.14 OA is the most widespread form of arthritis and causes those 
with the condition to suffer from joint pain and localised inflammation.68 Obesity is a known risk 
factor for OA, in particular that located in the knee.68 For instance, there is a 4-fold higher prevalence 
of knee OA among obese adults when compared to non-obese adults.14 While the exact mechanisms 
responsible are not well understood, cartilage degeneration from metabolic effects has been a 
suggested possibility.68 
 
Moreover, evidence of a relationship between obesity and other pain conditions, such as headache 
or migraine, has been well-documented.69, 103, 105, 138 For instance, morbidly obese individuals were 
found to have twice the risk of suffering from severe headache pain when compared to those of a 
normal weight.69 Obesity has also been linked to other chronic health conditions such as FM23, 118-123 
and RA.132-137 FM has no known cause and is a chronic pain condition characterised by widespread 
musculoskeletal pain and stiffness, physical fatigue and multiple other symptoms affecting activities 
of daily living.68 Similarly, obesity is also a risk factor for the development of RA, an autoimmune 
disease characterised by disability, joint pain and chronic inflammation.68 While research linking RA 
with obesity is inconclusive, a significant association between the two conditions has been identified 
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in the past with regards to alterations in body composition.68 It is believed that the accumulation of 
adipose tissue plays an important role in this disabling and degrading disease.68 
 
Back pain is another condition that has been linked to obesity. For instance, in a recent cross-sectional 
study of nine countries investigating the relationship between obesity and back pain, significantly 
higher odds ratios for back pain were identified among five (Finland, Russia, Poland, Spain, South 
Africa) of the nine included countries when classed as obese or morbidly obese by BMI.109 LBP in 
particular has also been researched in the context of its co-occurrence with obesity.14 The condition 
of LBP is classified as acute if the duration of symptoms is less than 6 weeks, with subacute between 
6 weeks and 3 months, and chronic occurring for greater than 3 months.14 Janke et al. (2007) 
suggested there was inconclusive evidence linking excess weight with LBP, due to ambiguity 
surrounding the possibility of a direct relationship, the strength of the relationship if one is present 
and the conditions under which such a relationship may exist.14 They concluded it remains unknown 
if the relationship between obesity and LBP is causal, and raised the notion that varying definitions 
of LBP among research studies makes deductions challenging.14 However, a relationship between 
obesity and LBP has been demonstrated in the past, mainly with the use of BMI as an obesity 
measure.71, 74, 76, 78, 139  Moreover, recent research has found that individuals reporting high levels of 
pain intensity in the previous six months had significantly higher mean total body adiposity than those 
that reported no pain.80 Furthermore, increased adiposity (total body, upper and lower limbs, trunk, 
android and gynoid) was associated with higher levels of LBP intensity and disability.80 
 
In addition to general adult populations, research has also shown links between obesity and pain 
complaints and diagnoses among specific populations, such as veterans.14, 67 Furthermore, the 
presence of pain in obese populations is implicated across multiple age groups, including children,67, 
106, 140 adolescents,67, 106, 140 and the elderly.67, 110, 116 For example, there are clear linkages between 
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obesity and knee OA among young, middle-aged and older adults.14 In a cross-sectional study of 840 
participants aged 70 years and over, obesity was significantly associated with the likelihood of chronic 
pain across most areas of the body including the head, neck, shoulders, back, arms and hands, legs 
and feet, pelvis, and abdomen.116 In a sub-sample of the same aging study, the presence of abdominal 
obesity was found to double the likelihood of chronic back, hip, knee, leg or upper extremity pain.110 
Similarly, higher rates of overweight and obesity have been observed in children and adolescents with 
chronic pain, which may contribute to activity limitations among young people.106 Moreover, the 
negative effects of obesity on health-related quality of life (HRQoL) among youth populations has 
been reported.140 For instance, the reductions in quality of life brought about by the simultaneous 
occurrence of obesity and LBP is suggested to be intensified in children and adolescents when 
compared to adults.68 Of greater consequence, the state of being overweight or obese early in life is 
now a known risk factor for pain development at later stages.14 
 
Together with the greater presence of pain with increasing levels of obesity,70 the array of pain 
conditions obesity is linked to, and the multiple population groups this relationship exists in, it may 
be the health implications associated with the co-existence of obesity and pain that is most 
important. For example, the combination of reduced physical function associated with overweight 
and obesity, in addition to the presence of chronic pain, has been suggested to be both the cause and 
consequence of obesity comorbidities, such as OA, sleep apnea, type 2 diabetes mellitus and 
psychosocial disorders.68 Moreover, the impact of pain through the increased frequency of pain-
related disability and reduced physical functioning has been specifically recognised among obese 
patients.141 In addition, obesity has been linked to poorer quality of life and impaired functional 
capacity in people suffering from chronic pain conditions.68 While this health impact may be specific 
to certain pain conditions, such as through the significant reductions in quality of life with 
simultaneous occurrences of LBP and obesity,68 it is clear that when various chronic pain conditions 
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(including FM, OA, RA and LBP) are paired with obesity, those patients usually exhibit poorer physical 
function.68 Not only is quality of life negatively impacted,14 but the co-occurrence of obesity and pain 
has detrimental overall health consequences, ultimately resulting in increased mortality rates among 
this population.67 It has been previously suggested that the obesity-pain relationship may be 
exacerbated by the concurrent effects that sedentary living and excess weight have on each other.68 
For example, a lack of physical activity contributes to obesity and directly or indirectly increases pain 
and disability, thereby further reducing physical activity.68 While a possible dose-response 
relationship between BMI and pain with resulting negative consequences on HRQoL has been 
identified, it was concluded that further clarification was required.14 
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2.3 The Focus: Obesity and Chronic Low Back Pain 
 
While overweight and obesity have been linked to various pain pathologies as outlined above, there 
is also evidence of a relationship between obesity and LBP that is chronic in nature.23, 71-80 For 
example, individuals classified as overweight or obese may be at greater risk of cLBP development 
than those of a normal weight.78, 81 In a twin-based study on overweight, obesity and reporting of 
chronic pain symptoms and diagnoses, cLBP was the most commonly diagnosed condition (26% of 
study participants).23 Both overweight and obese individuals were significantly associated with cLBP, 
and remained significant after adjustment for age, gender and depression.23 Irrespective of such 
findings, discrepancy exists among the literature regarding gender. For example, Heuch et al.74 
identified a significant positive association between BMI and chronically-occurring LBP74 that was 
present across both genders. Conversely, associations between obesity measures and cLBP have not 
been consistently significant for men in other studies,78 particularly after adjustment for confounding 
variables.73 While associations between obesity and cLBP have been observed across both genders,74 
some studies have suggested the association is stronger among women.68, 74 A proposed explanation 
for this discrepancy included possible hormonal or adiposity differences between men and women.68  
 
Relationships between obesity and cLBP have been identified across a range of anthropometric 
measures. For example, in a 10-year prospective study of Norwegian men and women, overweight 
or obese individuals (measured by BMI) were at a greater risk of chronic pain in the lower back when 
compared to those of normal weight.78 However, the study design was admittedly limited by BMI 
being measured at baseline only, so changes within the 10-year follow-up period were not 
considered.78 Higher prevalence of cLBP among men and women with increasing measures of WC, 
waist-to-hip ratio (WHR) and BMI was also found in a study on the Dutch population.73 In this study, 
women with increased WC had greater odds of reporting cLBP than those with lower WC 
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measurements.73 Similar results were seen for BMI and WHR, whereby increased relative risk of cLBP 
was observed with greater WHR and BMI values.73 Both men and women with indications of 
overweight, obesity or heightened non-specific indices of adiposity were found to be at an increased 
risk of cLBP.73 After adjustment for confounding variables, these relationships between BMI, WC and 
WHR with cLBP remained significant for women only.73 Such gender-based differences may be better 
understood if adipose tissue is found to play a role in cLBP development.  
 
In a matched-control study on Japanese people with cLBP, it was found that WHR was significantly 
higher among women with a negative straight leg raise (SLR) test compared to age- and gender-
matched healthy controls.112 It was concluded that central obesity, as depicted by an elevated WHR, 
may be a risk factor for cLBP among women aged 45 to 69 years.112 While this study was limited to 
an older population, it was specific to cLBP and assessed several anthropometric and body 
composition variables. Such variables included BMI, percentage of total body adiposity (%TBF), lean 
body mass and WHR, across both subjects and control participants.112 Within the female sample 
assessed, %TBF was reported to be significantly higher in cLBP participants with negative SLR 
compared to controls.112 BMI was not associated with negative SLR cLBP participants.112 Interestingly, 
in addition to WHR and increased %TBF, reductions in lean body mass of the trunk and lower 
extremities relative to body weight were correlated to negative SLR cLBP.112 Therefore, it was 
suggested that the presence of central obesity and loss of trunk muscle mass may be implicated in 
the risk of non-sciatic cLBP in women aged 45-69.112 
 
Despite such evidence, it is difficult to draw firm conclusions from previous research into the 
relationship between obesity and cLBP. This is due to the limited number of studies on cLBP 
specifically, as opposed to generalised LBP. For example, in alignment with much of the previous 
research, BMI has been shown to predict LBP recurrence.68 Furthermore, both BMI and increased fat 
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mass have been associated with greater LBP intensity and disability.68 Moreover, there is a need for 
greater clarity of LBP or cLBP distinction in some studies. In the paper just mentioned,68 LBP is referred 
to in the context of a chronic condition. However, the distinction is not consistently clear, being 
coupled with citations from both LBP and cLBP research. It may be argued that this lack of clarity 
within the LBP research, both chronic and otherwise, hinders greater advances in understanding the 
relationship between obesity and pain conditions such as cLBP. In addition, conflicting findings have 
also been evident among past studies, including multiple literature reviews within this area (Table 
2.1).  
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Table 2.1 Reviews on the relationship between overweight/obesity and pain (including LBP) 
Ref. 
Article 
Author/s 
Pub. 
Year 
Type of 
Article 
No. of 
included 
studies 
Years 
included 
Outcomes of Interest Main Findings Author/s Conclusions 
68 Arranz et 
al. 
2014 Literature 
Review 
Not 
specified 
2000 – 
2013  
Effects of obesity on 
chronic pain, particularly 
QoL and functional 
capacity. 
Obesity is associated with 
increased prevalence of LBP. 
Causal relationship between high 
BMI and LBP is controversial. 
Overweight/obese 
people have higher 
prevalence of chronic 
pain co-morbidities 
(FM, OA, RA, LBP) and 
worse functional 
capacity and QoL. 
More research needed 
on pathophysiologic 
mechanism of excess 
body weight and pain 
142 Garzillo & 
Garzillo 
1994 Literature 
Review 
7 1970 – 
1994 (?) 
Association between 
obesity and LBP. 
Poor correlation between 
weight/BMI and LBP (especially in 
lower 80% of BMI. Good 
correlation in upper 20% of BMI. 
Possible association 
between obesity and 
LBP in upper quintile 
of obesity only. No 
evidence of temporal 
relationship. 
75 Leboeuf-
Yde 
2000 Systematic 
Literature 
Review 
65 1965 – 
1997  
To determine if body 
weight is associated with 
LBP and if the link is 
causal. 
Significant positive association 
between weight or relative weight 
and LBP in 21 of 65 (32%) studies. 
No obvious consistency of findings 
among large general population-
based studies. 
Not enough evidence 
to determine if causal 
relationship between 
body weight and LBP. 
14 Janke et 
al. 
2007 Literature 
Review 
Not 
specified 
2000 – 
March 
2006 
To examine the 
relationship between 
weight and pain with 4 
focuses: 1) commonly 
researched pain 
Relationship between obesity and 
pain (eg. OA, possibly LBP) 
supported by cross-sectional 
studies. Overweight/obesity early 
in life possible risk factor for 
Likely relationship 
between overweight 
or obesity and pain 
(based on available 
evidence). More 
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conditions in co-
occurrence to 
overweight/obesity (incl. 
LBP); 2) relationship 
between HRQoL, pain and 
obesity; 3) weight 
reduction effects on pain, 
and pain treatment on 
weight reduction; 4) 
possible explanatory 
mechanisms. 
LBP/OA development (longitudinal 
studies). Possible dose-response 
relationship between BMI and 
pain. HRQoL negatively impacted 
by obesity-pain co-occurrence. 
information needed 
on the nature of the 
relationship.  
97 Shiri et al. 2010 Meta-
analysis 
33 1966 – 
May 2009  
Association between 
overweight/obesity and 
LBP, and estimate 
magnitude of association. 
Obesity associated with increased 
LBP prevalence in last 12 months, 
cLBP or LBP seeking care (cross-
sectional studies). Overweight 
people have higher LBP prevalence 
than normal weight. Obese people 
have higher prevalence than those 
overweight. Obesity associated 
with increased LBP incidence ≥1 
day in past 12 months (cohort 
studies).  
Overweight/obesity 
increases the risk of 
LBP. 
77 Mirtz & 
Greene 
2005 Literature 
Review 
8 1990 – 
2004  
To determine if there is a 
causal link between 
obesity and LBP. 
Direct association for obesity as 
risk factor in 2 studies. No 
association in 2 studies. Several 
studies not in agreement to 
cause/association. Several studies 
unable to clarify BMI adequately.  
BMI<30 minimal risk of 
LBP. BMI>30 moderate 
risk of LBP 
development. BMI>40 
at high risk. No 
definitive causal link 
between obesity and 
LBP. Data appears 
controversial. 
QoL, quality of life; HRQoL, health-related quality of life; FM, fibromyalgia; OA, osteoarthritis; RA, rheumatoid arthritis; LBP, low back pain 
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Multiple reviews have concluded there is insufficient evidence to confirm a relationship, causal or 
otherwise, between body weight or obesity and LBP.14, 68, 75, 77 There seems to be a trend of 
inconsistency among reviews on body weight or obesity and LBP, regarding reporting of populations, 
outcome measurements and study findings. Factors possibly impacting on the ability to draw 
conclusions from the research include varying body weight measurements,75 and difficulty 
deciphering LBP definitions.14, 75 For example, the lack of standard definition and diagnostic certainty 
for the LBP condition has been raised.14 As a result, the frequency and chronicity of pain measurement 
differs among studies and makes the relationship between overweight or obesity and LBP challenging 
to discern.14 Moreover, cLBP definitions vary even among reviews. A meta-analysis defined cLBP as 
pain lasting for greater than 7-12 weeks, or an excess of 30 days within the previous 12 months.97 In 
contrast, a separate review referred to cLBP as LBP occurring for more than 3 months.14 This variance 
has arisen in a simple definition of cLBP between two papers reviewing similar research, irrespective 
of the multiple other possible sources of disparity in outcome measurement, definition or reporting. 
Therefore, it is not difficult to identify why evidence of an obesity-cLBP relationship may appear 
controversial at best. 
 
Another identified limitation of past research is poor BMI classification.77 This has included unclear 
distinction between overweight and obesity, and various BMI cutoff points.97 For example, some 
studies examined in a meta-analysis deviated from the World Health Organisation’s (WHO) BMI value 
of ≥30.0 for obesity3 by using a BMI≥27.0 or ≥28.5 cutoff.97 For this reason, the meta-analysis included 
a combined overweight/obese category of BMI ≥25.0, with studies using BMI≥24.0 for 
overweight/obese or ≥28.5 for obese also included.97 This variance of obesity classification generates 
confusion and may produce inaccuracies among study findings. The meta-analysis also revealed that 
13 out of 24 cross-sectional studies relied on self-reported height and weight,97 which further raises 
the possibility of error. The authors proposed that the lack of consistency of overweight and obesity 
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cutoff points as per the WHO guidelines, in addition to several studies failing to report frequency, 
severity or case definition of LBP, may lead to possible underestimation of the strength of the obesity-
LBP association.97 Another limitation raised by multiple reviews is that LBP is typically a reference to 
a symptom rather than a confirmed diagnosis.14, 77 This may further hinder the understanding of a 
possible association between obesity and LBP, and make determining a possible cause and effect 
more challenging.77 
 
It has been revealed that few studies have explored causal relationships between weight or obesity 
and LBP, chronic or otherwise.14 Although several reviews have supported the possible existence of 
a relationship between overweight or obesity and LBP,14, 68, 75, 77, 97, 142 there is little evidence within 
the current scientific community to indicate a direct relationship.14 Moreover, it appears generally 
accepted that existing findings are inconsistent and inconclusive, so additional research is needed to 
determine the extent of the relationship.14, 75, 77, 142 Some suggested reasons for the lack of knowledge 
about the relationship between overweight or obesity and LBP include a weaker association between 
the two conditions than previously hypothesised.14 Another possibility was poor classification of the 
term ‘LBP’ and its reference to a non-specific disease with unknown etiology.14 Additional suggestions 
included research into weight and LBP being secondary exploratory work with a lack of hypothesis-
driven research questions, or the existence of other mediating factors between weight and LBP 
requiring further investigation.14 It has also been suggested that this association may be bi-
directional, in which obesity could either be a cause or consequence of LBP.97  
 
Such reviews reveal important considerations omitted from previous literature, which hinder the 
ability to deduce the exact relationship between obesity and cLBP. As mentioned earlier, there have 
been several different LBP definitions and body weight measurements used in the past.75 For 
example, the variance of reported frequency and chronicity of pain between studies has made 
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conclusions regarding obesity and LBP difficult to decipher.14 Exploring such relationships may 
continue to be problematic until a standard definition for LBP has been firmly established, and the 
certainty of diagnosis is widely and consistently used. Moreover, one of the issues with body weight 
measurements in previous studies is the poor classification of BMI,77 which is a common measure of 
obesity among LBP literature.71, 74, 76, 78, 139 This was previously alluded to in a meta-analysis, which 
raised the issue of multiple BMI cutoff points amid studies, and unclear delineation between 
overweight and obesity.97 This is an important issue, as some studies have only identified associations 
between obesity and LBP in the higher percentiles of BMI.142 Furthermore, since the prevalence of 
chronically-occurring LBP rises with increasing WC, WHR and BMI,73 such cutoff points of 
measurements like BMI may be of great significance. In addition, there is a general consensus that 
further research is required to better understand this relationship and the potential factors that may 
be interceding it.     
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2.4 Physical Activity and the Obesity-cLBP Relationship 
 
Physical activity may be another important consideration in the obesity-cLBP relationship. In a 
literature review of 16 studies on exercise for cLBP in overweight or obese populations, exercise was 
found to be a beneficial method of management for obesity and obesity-related comorbidities.143 
Moreover, a study comparing different types of exercise (general aerobic and strengthening exercise, 
aquatic exercise, home-based aerobics) to non-active controls confirmed that physical activity was 
more effective than inactivity for pain and disability improvement.144 A recently proposed pathway 
explaining links between exercise, obesity and LBP suggests inactivity may contribute to worsening 
LBP symptoms and increased weight gain, whereas exercise may improve pain and physical function 
and assist in weight management.143 
 
Physical inactivity may be further implicated in the obesity-cLBP relationship, since it is associated 
with an increased risk of LBP.78, 111, 145 More specifically, the highest risk of LBP has been found in 
obese individuals who maintain sedentary behaviours, with the greatest effect shown in WC-
measured abdominal obesity rather than BMI-derived general obesity.111 In contrast, no risk of LBP 
was identified in obese participants who were physically active.111 It was concluded that the impact 
of physical activity levels on LBP may be altered by obesity, or that both obesity and sedentary 
behaviours may amplify the influence of each factor on LBP occurrence.111 However, these results 
were only found in radiating LBP and were not observed among those with non-specific LBP.111 
 
Associations between physical activity and odds of LBP among overweight and obese individuals have 
also been identified in other studies.78, 145 For example, weekly leisure-time exercise was shown to be 
inversely associated with cLBP risk.78 Combined effects of BMI and exercise showed that ≥1 hour of 
exercise on a weekly basis reduced cLBP risk in both men and women regardless of baseline BMI.78 
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However, obese men and women who were inactive had a higher risk ratio for LBP compared to their 
active counterparts (in both obese and healthy participants).78 It was proposed that a small amount 
of exercise per week (1-1.9 hours) could reduce cLBP risk,78 which has also been supported by other 
research.145 For example, increasing time spent performing moderate physical activity by an average 
of 17.6 minutes per day resulted in a 32% lower LBP risk for overweight individuals.145 Moreover, risk 
of LBP was reduced by 38% in morbidly obese individuals from minimal increases in moderate 
physical activity (1.3-2.1 minutes/day).145 Therefore, physical activity was concluded to be an 
independent predictor of LBP, after statistical removal of BMI.145 The most predictive effects of 
physical activity on LBP were within moderate- and high-intensity ranges, but the effects were 
small.145 However, when BMI was included, sedentary and moderate physical activity time had the 
greatest influence on LBP.145 Such findings may suggest that inactivity and consequently obesity may 
be a potential result of LBP, or that obesity may lead to LBP and inactivity, or alternatively that 
increased sedentary living may result in either LBP or obesity.143, 145 It has been further suggested that 
exercise may bring about a protective effect on LBP, particularly among overweight and obese 
populations.145 This was supported by a review comparing different types of exercise for LBP, in which 
significant improvement in pain, physical function and muscular strength were observed after 2-4 
months of resistance training, aquatic exercise or Pilates.143 One possible rationale for a protective 
effect of exercise may the result of reductions in low-grade systemic inflammation brought about by 
physical exercise.78, 111 
 
A further consideration in the obesity-cLBP relationship may be physical activity for the purpose of, 
or independent of, weight loss, which is a typical goal among overweight and obese populations.143 
There is currently inconclusive evidence to indicate whether weight loss is the determining factor for 
LBP improvements following exercise. More specifically, individuals who are overweight or obese are 
advised to remain physically active regardless of weight reduction,111 since greater risk of radiating 
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LBP has been associated with obesity but not excess body weight.111 However, there is also existing 
evidence supporting weight loss outcomes among obese individuals with LBP.146 Following a 52-week 
weight loss program on obese adults, both weight and BMI were reduced, with trends towards LBP 
reductions and disability improvements.146 Moreover, positively-associated trends for clinically 
meaningful reductions in LBP were identified with higher percentage reductions in BMI at week 53.146 
Authors suggested those who had observed and continued weight loss were more likely to reduce 
LBP symptoms, with a possible explanation being the attenuation of low-grade systemic inflammation 
from combined effects of weight loss and increased daily physical activity.146 While weight loss was 
suggested to be the primary factor eliciting LBP and disability improvement, a key limitation of the 
study was the lack of a control group.146 Given the substantial duration of the study, the 
acknowledged inability to observe general severity of LBP among obese adults and natural 
fluctuations in weight or weight loss146 limited the generalisability of the study.  
 
With consideration of the existing research on possible influences of physical activity on the obesity-
cLBP relationship, the limited number of studies in this area makes it difficult to draw firm 
conclusions. Moreover, variance among studies regarding physical activity or exercise modalities, LBP 
definitions and types, and methods of obesity measurement also restrict the ability to compare such 
findings. 
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2.5 The Experimental Context 
 
Before extrapolating potential mediating pathways in the obesity-cLBP relationship, the existing body 
of evidence suggesting mediators in the relationship between obesity and pain must first be 
examined. As highlighted earlier, previous research has included general studies on obesity and pain 
as well as more specific studies on LBP, chronic pain or cLBP. In this section, all research within the 
context of obesity and pain will be considered. In the past it has been suggested that the association 
between obesity and pain may be bi-directional.116 Alternatively, it may be possible for obesity to 
merely be a marker for a true causal factor, or combination of factors.72 For example, the association 
between obesity and greater risk of pain may not be directly linked, but rather a mediation of one or 
more interrelated variables.67, 70  
 
2.5.1 Previous research into mediating factors between obesity and pain 
 
Two commonly considered mechanisms underlying a relationship between obesity and pain are those 
of a mechanical or inflammatory nature. For example, it has been suggested that excessive weight 
among children may bring about greater risk of pain and injury through increased stress on the 
musculoskeletal system.106 Much of the research surrounding obesity and pain has focused on LBP. 
While some evidence exists to support a causal link between obesity and LBP,71 the possible 
contribution of obesity on LBP development or vice versa is a contentious topic.108 Yet, it is known 
that LBP symptoms are worsened by the co-occurrence of obesity.108 Moreover, it has been suggested 
that obesity places an abnormal load on the lumbar spine and may therefore predispose it to 
mechanical disadvantage.72 For example, the heightened load on the body brought about by excess 
body weight may have a detrimental mechanical impact on the spine.71 It was suggested that the 
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prolonged state of excess body weight may place greater compressive loading on intervertebral discs 
or create additional spinal stress during functional tasks, both of which may lead to LBP.73 More 
importantly, there have been further suggestions that obesity-induced mechanical loading of the 
lower back region may be dependent on body morphology, or somatotype,147 whereby the greatest 
effect would be observed among those with central adiposity.147 In a recent study on body segment 
inertial parameters, increases in trunk moments of inertia and radii of gyration were observed among 
people with central adiposity.147 They discovered a 20% increase in body mass distribution to the 
trunk relative to that of normal BMI, and concluded that central adiposity-dependent mechanical 
loading was observed.147 The effects of greater centrally-accumulated adiposity on body mechanics 
may also include gait and shock absorption changes, predisposing the spine to further strain.73 For 
instance, it was suggested the lumbar spine may be subject to increased compressive or shear forces 
as a consequence of obesity.97 A final suggestion was an association via disc degeneration, whereby 
obesity leads to reduced spinal mobility and consequential disc nutrition interference and triglyceride 
alteration.97 Obesity may then lead to increased risk of degeneration of intervertebral discs and 
therefore a heightened chance of suffering from LBP.97 For example, Yang et al. observed associations 
between increased abdominal and sagittal diameters with greater odds of severe lumbar disc 
degeneration.148 
 
Another consideration is that adiposity may play a role in the obesity-pain relationship as a result of 
systemic inflammation. For instance, it is known that adipose tissue is an active organ with a role in 
inflammation regulation.68 More specifically, adipose tissue is involved in the production of cytokines 
contributing to a pro-inflammatory state, such as interleukin-6 (IL-6) and tumour necrosis factor alpha 
(TNF-α).79 In turn, C-reactive protein (CRP) is released which given its multiple sources of production, 
acts as a non-specific inflammatory marker of adipose tissue.79 With respect to associations between 
obesity and pain pathologies, adipose tissue has been previously implicated.149-151 For example, 
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adiposopathy (‘sick fat’ syndrome) is a state of elevated BMI and chronic systemic inflammation, 
whereby metabolic changes occur within the body in response to increasing adiposity.152 Research 
suggests that the presence of adiposopathy is the determining factor for musculoskeletal pain to 
coincide with BMI increases.152 Moreover, there are established links between adiposity and specific 
pain pathologies. For example, associations between obesity and RA have been more attributed to 
body composition changes than BMI.68 It was proposed that the accumulation of adipose tissue, 
perhaps triggered by metabolic dysfunction as a result of the chronic inflammatory state of RA, is 
believed to play a key role in the disease.68 Inflammation and the metabolic syndrome have also been 
proposed mechanistic possibilities in the association between overweight/obesity and LBP via 
adipose tissue distribution.97 There are multiple potential mediating pathways between adipose 
tissue and back pain, including adiposity-induced metabolic changes.80 For instance, the obesity-LBP 
link may exist by means of chronic systemic inflammation, in which the proliferation of pro-
inflammatory cytokines and acute-phase reactants accompanying obesity may give rise to pain.97 
Another proposed mechanism of action was a “pathomechanical pathway”97 between the metabolic 
syndrome and LBP, given the existing associations between several components of the syndrome and 
LBP including abdominal obesity, hypertension and dyslipidemia.97  
 
Not only has there been established links and proposed mediating pathways between obesity and 
pain conditions such as LBP, but research has also extended this relationship to pain chronicity. 
Although only generalised to the elderly population, it was observed that those with abdominal 
obesity were close to twice as likely to experience chronic pain.116 Moreover, this finding was 
independent of several other relevant factors to the obesity-pain association, including high-
sensitivity CRP, psychological disorders, pain co-morbidities and remaining metabolic syndrome 
components, thereby suggesting some other mechanistic link between obesity and pain.116 Obesity 
has been associated with a twofold greater likelihood of chronic pain in people aged 70 years and 
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over when compared to people of normal weight, which increases to four times more likely in those 
severely obese.110 One possibility that may explain the association between obesity and chronic pain 
is the increased mechanical demand on joints with a weight-bearing role.110 However, there may also 
be other factors, given obesity has been found to have significant associations to both weight-bearing 
and non-weight-bearing body sites.110, 151 The mechanisms responsible for the overweight or obesity 
and chronic pain relationship are not well understood, but evidently may be the result of multiple 
factors.23 For example, people who are overweight or obese are more susceptible to a pro-
inflammatory state, which is compounded by an increased prevalence of chronic pain conditions.68 
Research suggests that the onset and persistence of chronic pain may in part be due to chronic 
systemic inflammation.68 As previously suggested, the effect that obesity has on the body may be 
explained by adipose tissue leading to pain susceptibility from altered metabolic processes.116 In 
contrast, the chronicity of pain may stimulate the secretion of cortisol, which plays a role in central 
obesity.116 There is also a rising body of research that musculoskeletal condition development may 
be instigated by metabolic considerations, such as through cytokine release and adipokine 
mediation.80 Specifically, the release of pro-inflammatory factors amplifies the inflammatory state of 
the spine, thereby intensifying the pain experience, and possibly instigating a chronic pain state as a 
result of consequential tissue damage.80 
 
It is known that increased levels of inflammatory markers such as TNF-α, IL-6 and CRP have been 
linked to obesity, rendering the body to a state of pro-inflammation.110 Therefore, it has been 
proposed that inflammation may be a mediating factor between obesity and chronic pain.110 Yet the 
directionality of the relationship remains unknown.110 For example, pain prevalence may be 
augmented by obesity if pro-inflammatory cytokines are found to cause greater predisposition to 
pain.110 A possible suggestion for the chronicity of LBP among many individuals is that the excess 
weight of obesity exacerbates existing pain to the point that it becomes persistent.76 However, it 
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seems to be more specifically related to central adiposity, since distribution of adipose tissue around 
the body is more closely related to cLBP risk than overall BMI.112 Additionally, elevated WC and WHR 
have also been associated with occurrence of the chronic disease FM in women, but BMI and weight 
were not.87 The authors suggested the possibility that there may be a “bias toward central adiposity” 
in obese women with FM.87 
 
Therefore, it has been concluded that the mechanisms responsible for the interacting relationship 
between obesity and chronic pain in the adult population may include mechanical, metabolic or 
behavioural factors.140 The obesity-pain relationship may be attributed to physical loading 
considerations but also systemic mechanistic factors, since fat mass rather than fat-free mass was 
important to multisite pain.149 The inflammatory substances released from metabolically-active 
adipose tissue have demonstrated effects on joint structures, nociceptive pain pathways and chronic 
pain development and progression.149 Moreover, the mechanical musculoskeletal impairment 
brought about by excess weight and possible chronic inflammation may lead to reduced physical 
function and chronic pain presence.68 Such factors have been proposed as both the cause and 
consequence of obesity comorbidities, such as OA, sleep apnea, type 2 diabetes mellitus and 
psychosocial disorders.68 To conclude, it has been established that excess body weight and obesity 
contributes to chronic pain, with two commonly proposed mechanisms responsible for this 
interaction. The suggested mechanisms are mechanical stress on the musculoskeletal system and 
increased pain from systemic inflammation, yet a combined mechanical and systemic effect 
mediating the obesity-pain relationship may also be possible.14, 68  
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2.5.2 Consideration of the possible mediators in the relationship between obesity and 
cLBP  
 
Inflammation is a proposed mediator of the association between obesity and chronic pain.110 
Distribution of adipose tissue, an active organ and known contributor to inflammation regulation,68 
is more strongly related to the risk of cLBP than BMI.112 As a result, it is reasonable to believe that the 
association between obesity and cLBP may be based on the inflammatory response of the body, and 
the metabolic interaction between adipose tissue and pain receptors. Moreover, this interacting 
physiology of adipose tissue and pain may further stimulate chronic low-grade inflammation and 
promote the persistence of pain, since obesity has been previously implicated in the exacerbation 
and prolonging of existing LBP.76 Alternatively, it is also possible that the obesity-cLBP relationship 
may be the result of a mechanical mediation pathway, such as changes in spinal positioning, or the 
consequence that extra body mass and its distribution around the body has on the pain experience. 
There is also support for such a mechanical mediation, since previous research has indicated that 
obesity-chronic pain links may be explained by greater demand on weight-bearing joints.110 
Additionally, the excess body weight of obesity places an abnormal load on the lumbar spine,72 such 
as increased compression forces on intervertebral discs.73 Such forces may then predispose the spine 
to mechanical disadvantage.72   
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2.5.2.1 A metabolic pathway: Inflammation 
 
Inflammation may mediate the obesity-cLBP relationship, since an altered immune response 
involving chronic low-grade metabolic inflammation (‘metaflammation’) has been proposed to be the 
linking factor between type 2 diabetes mellitus, metabolic syndrome, insulin resistance, endothelial 
dysfunction and cardiovascular disease,153 and underlies most if not all forms of chronic disease.91 For 
example, there are multiple inflammatory markers of significance to both obesity and migraine 
pathophysiology, including CRP, Il-6, substance P, TNF-α, mast cells, macrophages, orexins and 
calcitonin gene-related peptide (CGRP).25 Such inflammatory markers have been shown to increase 
migraine frequency, severity and duration.25 Since past evidence indicates a relationship between 
obesity and migraine69, 103, 105, 138 with relevant inflammatory markers to that relationship,25 it is logical 
to conclude that there may also be a relationship between obesity and other chronic pain conditions 
such as cLBP. For example, there is evidence of dysregulation and dysfunction of pain processing 
pathways in cLBP in a similar manner to other chronic pain states, such as FM.154, 155 Several conditions 
with similar underlying pathophysiological dysfunction have been previously termed as ‘central 
sensitivity syndromes’, which includes tension-type headache, migraine, interstitial cystitis, FM and 
temporomandibular disorders.156 The commonality of pain processing dysfunction among known 
disorders, as mentioned above, therefore makes the possibility of similar dysfunction in cLBP 
plausible. More specifically, metaflammation may mediate the obesity-cLBP relationship (Figure 2.1). 
This may occur through metabolic and physiological processes occurring within adipose tissue, in 
which increased adiposity stimulates inflammation and further promotes the persistence of chronic 
pain.80, 91-93  
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Figure 2.1 A proposed model of the inflammation-related mediation in the relationship between 
obesity and cLBP. Solid arrows indicate evidence of a relationship. Dotted arrows indicate proposed 
relationships. 
 
Although cLBP does not appear to exhibit the widespread pain evident in other conditions,154 it does 
seem pathophysiologically similar to FM157 and may lead to FM development.158 Metabolic processes 
associated with excess adipose tissue may explain the relationship between adiposity and back pain 
and disability.80 As mentioned earlier, adipose tissue is not only an organ passively storing excess 
energy, but is actively involved in inflammation regulation.68 It is also thought to be directly involved 
in the pathophysiology of obesity-related diseases.96 For example, the overflow of adipocyte cells into 
excess visceral and ectopic (blood, liver and muscle) stores is known to initiate a process of metabolic 
dysfunction, contributing to insulin resistance and end-stage disease.91 Furthermore, a state of 
positive energy balance typically due to physical inactivity or excessive caloric intake, would lead to 
this accumulation of adipose tissue and subsequently adipocyte hypertrophy.93 The consequence of 
adipocyte hypertrophy is then macrophage and T cell infiltration.93 Such infiltration stimulates 
increased production and release of pro-inflammatory cytokines (eg. TNF-α and Il-6) and reduced 
production and release of anti-inflammatory cytokines (eg. adiponectin).93 As a result, the release of 
pro-inflammatory cytokines through activated immune cells may produce heightened nociceptor 
activity101 and hyperalgesia.92 As previously discussed, NMDA receptor activation and lowering of the 
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depolarization threshold then leads to an amplification of the overall pain response.91 The possibility 
that chronic low-grade inflammation could result from such pathophysiological processes, may then 
support the proposed metaflammation-mediated relationship between obesity and cLBP.93  
 
It is reasonable to believe that the inflammatory state initiated by excess adiposity can lead to the 
persistence of cLBP. For instance, it has been suggested that metabolic processes related to increased 
adiposity may be involved in the relationship between fat mass and back pain.80 The mechanism 
responsible for this relationship may be the inflammation incurred from the hypertrophy of 
adipocytes, which promotes the release of pro-inflammatory adipokines (adipocyte-specific 
cytokines) from adipose tissue.93 Additionally, the increased perception of pain that has been found 
in obese individuals,159 is said to be caused by a local release of chemical substances from neuronal 
and non-neuronal cells including immune cells.92 Since immune cells are known to release 
cytokines101 and possibly induce hyperalgesia,92 adipose tissue may be responsible for repeated 
primary sensitisation and expansion of the pain receptive field. As previously mentioned, repetition 
of the peripheral pain response leads to central sensitisation and further amplification of pain levels.92 
The end result of such processes is the suggested chronic pain state.92 Therefore, the relationship 
between obesity and cLBP may be attributed to hyperalgesia and central sensitisation driven by 
adiposity-derived inflammation. 
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2.5.2.2 A mechanical pathway: Abdominal to lumbar adiposity 
 
A second proposed mediation pathway for the obesity-cLBP relationship is that of a mechanical 
nature (Figure 2.2). 
 
 
 
 
 
 
Figure 2.2 An alternative model of a possible mechanical mediation between obesity and cLBP. Solid 
arrows indicate evidence of a relationship. Dotted arrows indicate proposed relationships. 
 
Mechanical loading may be an important consideration in the obesity-cLBP relationship. For example, 
it is possible that an association between spinal positioning and pain development exists. This may 
be evidenced by a pilot study comparing cyclists with and without flexion-provoked non-specific cLBP 
(NSCLBP). In this study, a trend towards greater flexion and axial rotation of the lower lumbar spine 
was observed among those with NSCLBP.95 The testing protocol required participants to cycle until 
the onset of LBP (pain group) or until general discomfort prevented further riding (non-pain group).95 
Although the findings failed to reach statistical significance, a large effect size indicated a trend 
towards greater flexion in the lower thoracic region of the spine. Moreover, when considered in 
conjunction with lower lumbar flexion angles, it was suggested there may be a clinically relevant 
difference in thoracolumbar flexion between pain and non-pain groups.95 Similarly, a study on 
industrial workers identified that those with flexion-related LBP adopted sitting postures with 
Obesity cLBP 
Mechanical 
loading 
↑spinal movement  
↑compressive forces 
↓muscle endurance 
40 
 
increased posterior pelvic tilt when compared to healthy controls.94 The LBP participants also sat with 
the lumbar spine closer to end of range flexion,94 thereby habitually adopting a more pain-provoking 
posture.94 An additional study on adolescents with NSCLBP also observed the tendency to adopt 
sitting postures of greater pain provocation.160 In that study, adolescents with extension-related 
NSCLBP sat in postures of greater lumbar lordosis, when compared to the flexion-related pain and 
control groups.160 O’Sullivan et al.94 suggested that such habitual loading of tissues already sensitised 
to pain responses may lead to further nociceptive sensitisation, resulting in greater tissue loading and 
a possible chronic pain state.94 The notion of pain sensitisation was also discussed by Burnett et al.,95 
whereby the observed movement pattern adopted preceded the task-induced onset of pain.95 Given 
the presence of an existing sensitisation to movement and loading associated with lumbar flexion, 
the authors suggested cyclists in the pain group appeared to adopt patterns of movement that further 
increased the flexion and rotational strain on the lumbar spine.95 It was proposed that rather than a 
reflexive mechanism to pain occurrence, the pattern employed was an “inherent movement fault.”95 
Spinal movement has also been observed during a trunk extension task among healthy male 
participants.161 During the final 30% of the return movement to upright, the lumbar spine and hip 
consistently exhibited an over-corrective shift into 2-6 degrees of flexion.161 Although the study only 
included healthy participants, it was proposed that the identified “phenomenon” of an 
overcorrection phase may be beneficial in understanding lumbar spine and hip kinematics in LBP 
sufferers.161 
 
In addition to the lack of statistical significance resulting from riding posture and small sample size,95 
further limitations exist within the cycling study. The observed spinal movement trends coincided 
with pain development, indicated by the increase in pain reported at the end of the ride compared 
to baseline scores.95 However, the study claimed to cease testing at the onset of pain and also refers 
to LBP participants reaching a point where cycling had to cease.95 Therefore, there is insufficient 
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information provided to deduce whether this is at onset of pain or not. The study also requires greater 
clarification with respect to grouping. For example, groups were claimed to be matched as closely as 
possible by age, height, weight and BMI,95 but later by 1) total ride time, 2) ride position and 3) 
height.95 As a result, it is unclear precisely how groups were matched. A further limitation was that 
neither of the cycling or sitting studies included the consideration of adiposity and body mass 
distribution. Although cycling and seated postures are body weight-supported tasks, it is possible that 
such factors may relate to the obesity-cLBP relationship by other means of mechanical loading. 
 
The mechanical loading associated with increased shear or compressive forces on the lumbar spine 
from excess adiposity may be one such factor. The lumbar spine is known to transmit the mechanical 
forces of compression to the lower body, to maintain upper body support during daily activity.162 It is 
possible that excess abdominal adiposity may heighten the gravitational pull on the lumbar spine and 
contribute to compensatory lordotic positions. Moreover, such alterations to normal daily posture 
may result in greater repetition or magnitude of compressive spinal loading, which is known to 
increase the risk of intervertebral disc injury.163 For example, an in vitro examination of axial 
compressive loading and flexion/extension motion effects on porcine spines, showed a greater 
likelihood of disc herniation with increased repetition of flexion/extension moments.163 This damage 
was observed with minimal joint compressive forces and was intensified with higher axial 
compression magnitudes.163 Moreover, increases in cyclic flexion/extension moments were 
suggested to generate cumulative and progressive damage.163 It may then be possible for the obesity-
cLBP relationship to manifest through adiposity-induced compressive loading or flexion/extension 
moments. Further support may be evidenced by another porcine study, in which models were 
exposed to combinations of compressive forces, postural deviation and shear displacement to 
produce vertebral joint failure.164 The study found that ultimate shear failure force was influenced by 
the deviation of posture from neutral, or by compression-related vertebral joint height reduction.164 
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Shear failure force was highest during extension (less space between articulating facets) and lowest 
during a flexed posture (facets further apart).164 Although ultimate shear failure force was impacted 
by increased compression,164 postural deviation was deemed of greatest consideration since flexion 
reduced the vertebral joint’s capacity to tolerate shear loads.164 A third porcine specimen study 
examined compressive loads and rotational torques to assess the impact of loading history and failure 
posture.165 This study also identified decreased compressive loading tolerance with full spinal 
flexion.165 More specifically, they identified a 43-63% lower yield point (the load at which stiffness 
decreased and injury originated) in a position of spinal flexion when compared to neutral posture.165 
A 23-47% lower ultimate compressive strength (maximum tolerable load before deformation 
increased) was also observed.165 Such studies may validate the possibility of a mechanical loading 
mediation in the obesity-cLBP relationship, since greater spinal movement may coincide with 
increased pain94, 95 and reduced loading tolerance.163-165 
 
The effects of compressive loading have been further demonstrated in a study on creep and recovery 
responses of human intervertebral discs of the spine.166 The study compared two experimental loads, 
a slow compression load of 2000N over 30 minutes and a rapidly applied creep load of 1000N held 
for 4 hours.166 The recovery time was found to be longer than the duration of loading, and the rate 
and duration of loading had an observed effect on recovery.166 For example, the discs exposed to the 
30-minute load exhibited an immediate recovery of 70% of displacement, but only a 20% recovery 
was observed immediately following the 4-hour loading.166 The mechanism of action was suggested 
to be time-dependent, whereby the externally applied forces of the creep loading impacted the 
osmotic pressure enough to initiate a rapid expulsion of fluid.166 In the unloaded recovery phase, only 
the osmotic pressure was present to facilitate the movement of fluid back into the disc so recovery 
was slower.166 Since the creep loading utilised in the study was representative of standing while 
holding an object, it may be possible to liken such loading to increases in body weight and particularly 
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that of greater abdominal adipose tissue. However, it remains unknown if this has an effect on pain 
experienced, since authors of the aforementioned cycling study rejected the possibility that back pain 
development results in the progressive deformation of spinal creep.95 The rationale provided was 
that spinal posture was not modified as a reflex pain response during the cycling task.95 Authors 
proposed that since back injury is increased with end of range strain, it may be possible for the trend 
towards increased flexion and rotation among pain group participants to be related to prolonged end 
of range strain.95 Since further clarification with respect to the onset of pain and exact test cessation 
was needed in the study, it is difficult to confirm or refute this possibility. 
 
It is also known that spinal stability is required for successful transmission of forces to the lower body, 
and that the degree of stability required is dependent on task demand and muscular involvement to 
prevent buckling under high loads.162 This was demonstrated by a study using a lumbar spine model 
to estimate stability during three-dimensional dynamic tasks.162 In this study, stability was found to 
be paramount during demanding tasks and increased with greater compressive forces.162 In contrast, 
stability of the spine decreased when it was not needed as critically and during tasks with little 
demand on muscular activity, perhaps to reduce energy expenditure.162 In these situations, the 
passive joint tissues such as discs and ligaments are believed to play an important role.162 It was 
suggested that a loss of stability at any given moment would result in unexpected spinal 
displacement, triggering nociceptive input from nerve roots or surrounding connective and soft 
tissues.162 The need for the recovery of spinal stability following displacement may then result in 
tissue overload.162 The authors concluded that less stable and demanding tasks such as standing 
present a greater risk of buckling, particularly if lower passive joint stiffness is also present.162 They 
also suggested that moments acting on the lumbar spine have to be balanced by musculature.162 
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Given the involvement of muscle force on the stability of the spine, there may be an underlying 
muscular mechanism contributing to the potential mechanical mediation of the obesity-cLBP 
relationship. For example, the distribution of body mass may play a role in spinal extensor muscle 
fatigue. More specifically, the greater abdominal adiposity may alter muscle recruitment strategies 
in functional body positions whereby posture is at play. It has been previously shown that people 
with NSCLBP display a trend towards increased muscle activation of some back extensors (erector 
spinae, multifidus) and abdominal muscles (rectus abdominis), with a reduction in the activation of 
other abdominal muscles (internal oblique) when compared to those without pain.95 Since such 
trends were observed in the presence of greater flexion and rotation moments, it was suggested that 
alterations in muscle activation may indicate a consequential pain response. Alternatively, the 
authors also proposed a counteraction to lower back flexion and rotation moments via increased 
extensor moments.95 For instance, during flexion the extensor muscles are required to produce an 
internal extensor moment to return the spine to an upright position, which is said to increase 
compressive forces on the vertebral joints.164 Moreover, an in vivo study of the feline lumbar spine 
showed that cyclic loading resulted in greater lumbar spine muscle activity, with repetitive exposure 
leading to viscoelastic creep and pain.167 The study involved 20 minutes of passive cyclic lumbar 
flexion to examine possible biomechanical and neurophysiological pathways in idiopathic low back 
and cumulative trauma disorders, commonly seen among workers performing repetitive lifting 
tasks.167 Study findings indicated that the greater the loading magnitude, the slower the recovery 
time.167 Moreover, even the minimum load of 20N was found to be sufficient to trigger the observed 
response.167 It is also known that a prolonged state of static flexion causes changes to the flexion-
relaxation muscle response, whereby the activity of the erector spinae muscles is heightened as a 
result of viscoelastic creep.168 During flexion and extension movements of the lumbar spine, the 
synergistic balance of loading between passive viscoelastic structures and lumbar musculature is 
required to counteract gravitational forces.168 If the forces produced by passive structures are not 
sufficient to support the weight of body structures against the force of gravity, the lumbar extensor 
45 
 
muscle activity must increase to compensate.168 The consequence of this imbalance may then be the 
disruption of optimal function and over-activation of extensor musculature.168 As suggested in the 
study on feline models of the lumbar spine, such increases in muscle activity may increase creep and 
pain development.167 Furthermore, the study on industrial workers with LBP discussed earlier 
identified a reduction in the endurance of lumbar musculature in those with flexion-provoked pain 
when compared to pain-free controls.94 They also found a significant association between decreased 
lumbar muscle endurance during the Biering-Sorensen test, and the increased posterior pelvic tilt 
observed during adopted sitting postures.94 Therefore, muscle activation changes and reduced 
lumbar muscle endurance may be associated with movement of the lumbar spine, and play a role in 
the provocation of LBP symptoms. Since research has also shown that obesity is linked to increased 
fatigability in tasks involving gravity counteraction,169 this possibility of a mechanical effect linking 
obesity with cLBP through muscle fatigue may be further strengthened.  
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2.6 Methods of Obesity Measurement 
 
Within the context of the potential relationship between adiposity and cLBP, it is important to 
examine the various methods previously used to assess levels of obesity and adiposity. 
 
Much of the previous obesity and cLBP research has relied on BMI as a measurement of obesity.71, 74, 
76, 78, 139 While BMI is a commonly used method for assessing the obesity of an individual,3, 14 
inadequacies of the measurement have been previously identified. Such inadequacy includes possible 
misclassification, resulting from a lack of distinction between fat and fat-free mass within the body.73, 
80 Given such limitations pertaining to the sole reliance on the BMI measurement, research has begun 
to investigate alternative methodologies for assessing body composition and adiposity, including 
bioelectrical impedance analysis (BIA)33-36, 170-181 and ultrasound (US).32, 90, 182-186 BIA is a method used 
to assess body composition and estimate an individual’s percentage of total body adiposity, based on 
the principle of impedance or resistance to the flow of an electrical current through the body.35, 173 
Despite previous concern regarding the use of universally applied body composition measures to both 
lean and obese populations,33 BIA has been shown to be a valid and reliable measure of total body 
adiposity (Table 2.2).33-36, 173, 176, 178, 179, 187-193 For example, a 2008 study on body composition in obese 
and non-obese men and women observed strong correlations (r>0.8) between BIA and the reference 
method dual-energy X-ray absorptiometry (DXA).33 Moreover, no statistically significant differences 
were identified between BIA and DXA for estimates of body composition, including %TBF, fat mass 
and fat-free mass.33 However, the authors concluded that accurate estimates of changes in body 
composition remained in question.33 Subsequently, a separate study also comparing BIA to DXA, 
examined the estimation of body composition changes following weight loss in young overweight 
women.36 The results of measurements before and after a 10-week weight loss intervention revealed 
good agreement and no significant differences between BIA and DXA for body composition variables 
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(including body composition changes).36 Although both single-frequency BIA (SF-BIA) and multi-
frequency BIA (MF-BIA) assessments were shown to be accurate in terms of bias and limits of 
agreement, MF-BIA was considered to be superior to SF-BIA.36 The reason provided was that SF-BIA 
tended to underestimate %TBF, whereas MF-BIA correlated more closely to DXA values.36 They 
further emphasised that hand-to-foot electrode placement was more accurate than foot-to-foot 
arrangement.36 Contrary to this, other studies have proposed SF-BIA to be of greater use.35, 187 
Moreover, some studies have concluded all methods of BIA tested to be reliable for body composition 
assessment.188, 193 Although wide limits of agreement have been previously identified for the BIA 
method,34-36, 187, 193 error values have been considered acceptable192 and consistently reported at 
approximately 2% difference to the reference method.34, 187, 189, 192, 193 Estimation errors for BIA have 
also been lower than the skinfold method.188 Several studies have supported the use of BIA for group 
or population studies.35, 190, 193 In a similar manner to BIA, other reference methods are not without 
flaws. DXA also has potential limitations,187 despite its common use as a reference method.33, 35, 36, 187, 
189, 190, 193 For example, DXA testing is expensive and requires specialised equipment and trained 
technicians.35 Comparatively, BIA requires little operator training,194 is on par with skinfold thickness 
testing194 and may be a more useful measurement than BMI at population level for the risk of obesity-
related chronic diseases.193 As such, BIA is a viable alternative for body composition assessment.36, 190, 
192   
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Table 2.2 Validity and reliability studies of bioelectrical impedance analysis methods to comparative methods of total body adiposity measurement 
Ref. Author/s 
Pub. 
Year 
Population 
tested 
N= BIA method used 
Comparison 
method  
Main Findings Author/s Conclusions 
33 Boneva-
Asiova and 
Boyanov 
2008 Obese and 
non-obese 
adult men and 
women 
283 Foot-to-foot 
(Tanita TBF-215) 
DXA %TBF was not significantly different 
from DXA. %TBF from BIA was highly 
correlated with DXA-derived 
measurements for males and females 
BMI<30, BMI 30-35 and BMI≥35 (r=0.83-
0.98, p<0.001). Correlations decreased 
for increasing BMI. 
Good correlation 
between body 
composition 
parameters derived 
from BIA and DXA. 
Body composition 
indices by DXA were 
not statistically 
different from BIA and 
were highly 
correlated. 
34 Chouinard 
et al. 
2007 Overweight 
adults, aged 
18-44 years 
38 SF-BIA Foot-to-
foot (Tanita TBF-
305) 
4C Model No significant differences in %TBF 
between Tanita and 4C Model at 
baseline. Tanita overestimated %TBF 
changes by 0.9% in the placebo group 
when compared to the 4C model. 
Significant correlations were identified 
between %TBF at 0 and 6 months for 
Tanita and 4C model (r≥0.90, p>0.001). 
No biases between methods were found 
at 0 or 6 months. Both methods 
detected %TBF changes, but BIA results 
did not reach statistical significance. 
The BIA method 
performed relatively 
well compared to the 
4C model in the 
accuracy of detecting 
%TBF changes in 
overweight adults, 
but had wide limits of 
agreement at the 
individual level. 
35 Pateyjohns 
et al. 
2006 Overweight or 
obese men, 
aged 25-60 
years 
43 MF-BIA 
(ImpediMed 
SFB7, Imp-MF), 
SF-BIA 
(ImpediMed 
DXA There was good relative agreement 
between DXA and all three BIA methods, 
with significant correlations for %TBF 
(Imp-MF, r2=0.69; Imp-SF, r2=0.40; 
Tanita, r2=0.44; all p<0.001). The 
SF-BIA methods (Imp-
SF and Tanita) may be 
useful in group 
comparisons, but use 
in individual body 
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DF50, Imp-SF), 
SF-BIA (Tanita 
UltimateScale, 
Tanita) 
absolute agreement between DXA and 
Imp-MF was poor (large bias, wide limits 
of agreement). Imp-SF and Tanita also 
had wide limits of agreement, but 
smaller bias than Imp-MF. There was no 
significant difference between DXA and 
Tanita values for %TBF. 
composition 
assessment may be 
limited.  
178 Ritchie et 
al. 
2005 Older adults, 
aged 55 years 
and over 
50 Foot-to-foot 
(Tanita, BF-556) 
Hand-to-
foot BIA 
(BIA 310) 
Significant correlation (r=0.84, p<.001) 
between hand-to-foot BIA and Tanita for 
%TBF and the 2 means not significantly 
different. %TBF correlated to BMI, WC 
and age (all p<.01) for both methods. 
Tanita BIA valid %TBF 
measure in older 
adults. 
36 Thomson 
et al. 
2007 Overweight or 
obese females, 
aged 18-38 
years 
24 SF-BIA (Tanita 
UltimateScale, 
Model 2000), 
MF-BIA 
(ImpediMed  
SFB7) 
DXA MF-BIA estimates showed good 
absolute agreement with DXA (small 
bias in %TBF), but wide limits of 
agreement, SF-BIA larger bias with wide 
limits for %TBF. During weight loss, MF-
BIA and SF-BIA not significantly different 
to DXA. No significant difference 
between DXA and MF-BIA for body 
composition (p≥0.88), significant 
correlation between MF-BIA and DXA 
for %TBF (r2=0.20, p=0.03). Significant 
difference between SF-BIA and DXA for 
body composition. Both SF-BIA and MF-
BIA accurate for body composition 
changes when compared to DXA. Prior 
to weight change, both SF-BIA and MF-
BIA showed moderate relative 
agreement for %TBF compared to DXA. 
BIA methods useful 
and valid alternative 
to DXA, good absolute 
and relative 
agreement for change 
in body composition. 
MF-BIA superior to 
SF-BIA when 
compared to DXA. 
 
 
 
 
 
188 Demura et 
al. 
2002 Young 
Japanese males 
50 Hand-to-hand 
(Omron HBF-
300), hand-to-
Underwater 
weighing 
(A&D, AD-
Significant differences were observed 
between BIA and underwater weighing, 
with %TBF higher using BIA. Correlations 
All BIA methods 
showed high 
reliability. Validity was 
50 
 
aged 18-27 
years 
foot (Selco SIF-
891) and foot-to-
foot (Tanita TBF-
102) 
6204), sum 
of skinfolds 
between BIA methods and underwater 
weighing were strong (hand-to-hand, 
r=0.708; hand-to-foot, r=0.878; foot-to-
foot, r=0.747) (all p<0.05). All three BIA 
methods showed high reliability 
(r=0.999).  
BIA tended to over- or underestimate 
%TBF in individuals with low or high 
relative body adiposity. Estimation 
errors were lower for BIA methods 
when compared to the skinfold method. 
highest using the 
hand-to-foot method 
of BIA. Correlation to 
underwater weighing 
was also high for 
hand-to-foot BIA, so 
this method of BIA is 
considered superior 
than the other two 
tested.  
191 Loenneke 
et al. 
2013 Male and 
female college 
students 
21 Foot-to-foot 
(Tanita model 
TBF-350), hand-
to-hand (Omron 
HBF-306C) 
3-site 
skinfold 
thickness 
There were no significant pairwise 
differences observed between repeat 
testing sessions (two visits on alternate 
days of the same week) for any of the 
methods tested. Pearson correlations 
ranged from r=0.933 to r=0.994 
(p<0.001). Intraclass correlations ranged 
from 0.93 to 0.992. Minimal differences 
ranged from 
1.8% for skinfold testing to 5.1% for TBF-
350 (athlete mode). 
Skinfold testing and 
the Omron (athlete 
mode) method were 
the most reliable 
methods of assessing 
(<2%) %TBF. The 
remaining methods 
produced minimal 
differences greater 
than 2%. 
187 Aandstad 
et al. 
2014 Male and 
female first-
year military 
cadets 
65 SF-BIA (RJL 
Quantum II), MF-
BIA (Biospace Co. 
InBody 720) 
DXA 
6-7 site 
skinfold 
thickness 
SF-BIA produced generally more reliable 
results than the skinfold method. MF-
BIA had wider limits of agreement, but 
higher validity results in men compared 
to SF-BIA. MF-BIA underestimated %TBF 
by approximately 2% when compared to 
DXA. 
The SF-BIA method 
was shown to be the 
most reliable and the 
most valid in women. 
In men, skinfolds or 
skinfolds and SF-BIA 
were the most valid. 
At an individual level, 
wide limits of 
agreement were 
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observed in 
comparison to DXA. 
189 Fornetti et 
al. 
1999 College-age 
female athletes 
(aged 18-27 
years) 
132 Hand-to-foot (RJL 
101A analyser) 
DXA High intraclass correlations were 
observed for BIA for single and repeat 
trial reliability. There were strong 
correlations between BIA and DXA. The 
prediction error was 1.8% for BIA when 
compared to DXA. Validity coefficients, 
standard error of measurements and 
total error values produced similar 
cross-validation results.  
BIA is a valid and 
reliable method for 
estimating body 
composition in the 
population tested, 
provided the given 
equations are used. 
193 Von Hurst 
et al. 
2016 Adult males 
and females, 
aged 18 years 
and over 
166 InBody 230 
(Biospace Co.) 
DXA and 
ADP 
Excellent relative agreement was 
observed for BIA to the estimated true 
value. Strong correlations were found 
between BIA with ADP and DXA (r2=0.88 
and respectively r2=0.92, but wide limits 
of agreement were observed. %TBF was 
consistently underestimated by 2% 
using the BIA method. Excellent 
reliability was shown for all methods 
using repeat measurements (<0.2% 
difference and small 95%CI). 
All methods were 
shown to be reliable. 
There was excellent 
relative agreement 
between BIA and 
comparative 
methods, but bias and 
wide limits of 
agreement were 
observed for absolute 
agreement.  
BIA may be a valid 
method for use in 
research and 
population studies.
  
190 Kafri et al. 2014 Stroke and TIA 
patients 
10, 
40 
MF-BIA (Maltron 
BioScan 920-2) 
DXA No significant differences in group 
means were found between BIA and 
DXA. Strong correlations were identified 
between BIA and DXA (%TBF for all BMI 
categories; r2=0.631, p=0.006). No 
statistically significant differences were 
Good agreement was 
shown between BIA 
and DXA. BIA may be 
of further use in 
research and clinical 
care. 
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observed between means of repeated 
measures (average 2–10 
measurements). Good reliability was 
shown using 80 measurement pairs. 
192 Moon et 
al. 
2008 Healthy 
college-age 
men 
31 RJL Quantum II Siri 3C 
Model 
BIA produced an acceptable total error 
value of 2.1%TBF and had the highest 
validity coefficient (r=0.91) and smallest 
limits of agreement of all field methods 
tested.  
  
BIA is a valid and 
acceptable field 
method for the 
assessment of %TBF 
when laboratory 
methods are not 
available. Error values 
for BIA were 
acceptable (≤4%TBF). 
BIA, bioelectrical impedance analysis; DXA, dual-energy X-ray absorptiometry; %TBF, percentage of total body adiposity; BMI, body mass index; WC, 
waist circumference; SF-BIA, single-frequency bioelectrical impedance analysis; MF-BIA, multi-frequency bioelectrical impedance analysis; 4C Model, 
Four-compartment model; 3C, three-compartment model; ADP, air displacement plethysmography; TIA, transient ischaemic attack 
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Since the regional distribution of adipose tissue, particularly visceral adiposity,88, 89, 195, 196 has been 
suggested to be more important than total body adiposity, it is necessary to acknowledge the various 
anthropometric and imaging methods used to assess regional adiposity. Anthropometric data 
includes WHR, WC and abdominal sagittal diameter, which are inexpensive and easily obtainable but 
have low accuracy and reproducibility.186 Imaging techniques include computed tomography (CT), 
magnetic resonance imaging (MRI) and sonography or US. While CT and MRI are highly reproducible 
and CT is a reference standard for adipose tissue evaluation, both methods are expensive.186 CT also 
involves ionising radiation, and MRI is less readily available and tends to overestimate adipose tissue 
deposits.186 US on the other hand has showed strong correlation to visceral adiposity evaluation with 
CT methods, and is safe, cost-effective and accurate.32, 186 US has been shown to be a valid and reliable 
method of assessing abdominal adiposity when compared to gold standard methods.32, 90, 182-184, 186 It 
involves taking linear measurements of adipose tissue thickness based on anatomical references such 
as the linea alba.32, 182 Unlike DXA, US can distinguish between visceral and subcutaneous adiposity.32 
Intra-abdominal adipose tissue thickness is a sonographic index used to measure visceral adiposity, 
which is highly reproducible and correlates well with CT.186 It is defined as “the distance between the 
anterior wall of the aorta and the posterior surface of the rectus abdominis muscle.”186 Intra-
abdominal adipose tissue thickness is correlated with cardiovascular risk factors, such as total and 
HDL-cholesterol, fasting glucose levels, triglyceride levels and fasting insulin.186 It is considered to be 
the most reliable adiposity index, based on its confirmed reproducibility among multiple patient 
groups, including healthy, obese and diabetic populations.186 Previous research has observed good 
accuracy for visceral adiposity and even stronger accuracy for subcutaneous measurements, when 
compared with CT.32 It was also found that there was significant reproducibility for obese and non-
obese patients, and excellent intra-operator reliability.32 However, the comparison between total 
body and regional adiposity as opposed to BMI and other anthropometric measures, is yet to be 
investigated in the cLBP population.  
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2.7 Summary 
 
It is possible that the missing link among all previous cLBP research may be the distribution of body 
mass, particularly that which is located in the abdominal region. For instance, the possibility of an 
inflammation-based mediating pathway between obesity and cLBP, may be a reason why 
abdominally-accumulated adiposity is paramount in the relationship. Alternatively, mechanical 
mechanisms may be responsible for the relationship between obesity and cLBP, such as through the 
effect that distribution of mass has on the body. For this reason, the studies included in this thesis 
are the necessary foundational steps to better define and understand the relationship between 
obesity and cLBP, and the potential factors mediating that relationship. It is plausible that the 
distribution of abdominal adiposity in cLBP individuals may be the uniting factor among obesity and 
cLBP research. Furthermore, adiposity distribution may link various elements of past LBP studies, 
including control of posture, spinal movement changes and task performance and fatigue. 
 
While multiple potential mediating factors in the relationship between obesity and cLBP are discussed 
in this thesis, not all of them were investigated within the context of the PhD. This thesis will not 
cover a detailed metabolic investigation or manipulation, or the observation of specific physiological 
pain processes. However, what will be explored is the current knowledge of the relationship between 
obesity and cLBP, in addition to some of the potential mediating pathways. This research will include 
the distribution of body mass and its link to pain, as well as the experience of cLBP individuals in 
postural task performance.  
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Chapter 3: No Relationship Between Body Mass Index and Changes in 
Pain and Disability Following Exercise Rehabilitation for Patients with 
Mild to Moderate Chronic Low Back Pain 
 
The text contained in this chapter was published in Spine in 2013.197 Please note that aspects of the 
published article have required modification to conform to the chapter-style thesis format, including 
citation numbers, headings, and formatting of tables and figures. The mini abstract and key points 
included in the published article have been omitted. 
 
3.1 Abstract  
 
3.1.1 Study design  
A retrospective, multi-centre study.  
 
3.1.2 Objective 
To investigate the relationship between BMI and changes in pain and disability resulting from 
exercise-based cLBP treatment. 
 
3.1.3 Summary of background data 
Past research has shown evidence of a relationship between BMI, a measurement of obesity, and 
cLBP. Exercise is a known beneficial treatment for cLBP. However, it is unclear if exercise-induced 
changes in pain and disability are related to baseline levels of, or changes in, BMI.  
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3.1.4 Methods 
One hundred and twenty-eight (n=128) men and women with cLBP performed eight weeks of 
exercise, consisting of three to five exercise sessions (minimum of one supervised) per week. 
Outcome measures included BMI and self-reported pain and disability. BMI was calculated by weight 
divided by height squared (kg/m2). Pain was measured using the Visual Analogue Scale (VAS) and 
disability was measured using the Oswestry Disability Index (ODI). Correlation, regression, covariance 
and likelihood ratios analyses were used to examine the relationship between BMI and self-reported 
pain and disability changes.  
 
3.1.5 Results 
No baseline relationships between BMI and self-reported pain (r=-0.083, p=0.349) and disability 
(r=0.090, p=0.314) were observed. There was no relationship observed between baseline BMI 
(r=0.938, p=0.873), or changes in BMI (r=0.402, p=0.854), with exercise-related changes in pain and 
disability respectively. No relationships between baseline BMI or BMI changes with pain and disability 
at baseline or following exercise were observed on the basis of pain and disability sub-groups. BMI 
was not a predictor of exercise-based pain and disability changes.  
 
3.1.6 Conclusions 
There was no significant relationship between BMI and self-reported pain and disability in cLBP 
participants. BMI was not a predictor of exercise-induced changes in pain and disability. The reliance 
on BMI as a sole measurement of obesity in cLBP research may be unwarranted. 
 
3.1.7 Key words 
Body mass index, chronic low back pain, self-reported pain and disability, exercise, obesity. 
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3.2 Introduction  
 
cLBP is a widespread, disabling health condition8, 10, 11 that affects 70-85% of people at some point in 
their life.5, 154 In Australia, it is estimated that cLBP costs $9.17 billion dollars annually13 as a result of 
treatment-related expenses and work absenteeism.10, 13 cLBP refers to pain below the costal margin 
and above the gluteal fold, lasting for a minimum of 12 consecutive weeks.4 Although the exact 
etiology of cLBP is unclear,198 a possible relationship between obesity and cLBP has become evident.6, 
23, 78 For example, it has been suggested that obesity may affect pain and disability levels in cLBP80 
and can increase the risk of future cLBP development.81  
 
Obesity is also a prevalent condition,3, 14 with 20-25% of the Australian population reported as 
obese.18 More importantly, obesity is common among low back pain sufferers.76 Obesity is 
characterised by excess adipose tissue contributing to metabolic dysfunction.2 A commonly used 
method to assess a person’s degree of obesity is BMI,3, 14 which is a known predictor of morbidity and 
mortality3, 77 that is widely accepted and easily measured. BMI is a measure calculated from weight 
divided by height squared (weight/height2).3 Classification categories for BMI include <18.5kg/m2 as 
underweight, 18.5-24.9kg/m2 normal weight, 25.0-29.9kg/m2 overweight, and ≥30.0kg/m2 obese.3, 78 
BMI has been criticised by its inability to discriminate between fat and fat-free mass within the body, 
leading to possible misclassification.73, 80 Regardless of such limitations, a relationship between BMI 
and cLBP has been identified.23, 81  
 
BMI has not only been included as an obesity measurement in cLBP research, but has been used as a 
sole outcome measure.23, 81 Research on the relationship between BMI and cLBP has produced 
conflicting results. For example, 21 of 65 included studies in a systematic review (32%) found a 
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significant weak but positive association between BMI or body weight and low back pain.75 The 
remaining 44 studies did not find this significant positive association, or did not report on such an 
association.75 Despite such inconsistent findings and lack of conclusive evidence for a definite link 
between BMI and cLBP, the regular use of BMI in cLBP research make it important for this relationship 
to be explored. More specifically, no studies have investigated the BMI-cLBP relationship with respect 
to pain and disability changes following a known treatment intervention, such as exercise. This is of 
importance, since exercise is a first-choice treatment for patients with cLBP.85, 86  
 
Recent findings suggest that exercise may moderate the relationship between obesity and cLBP. For 
example, while overweight and obesity increase the risk of cLBP,80 obese men and women exercising 
for one or more hours per week had 20% lower risk of cLBP than those that were inactive.78 It remains 
unknown if BMI is associated with changes in pain and disability following exercise interventions for 
cLBP. Since BMI has been consistently used in cLBP research and shown to be associated with cLBP 
at baseline,74, 80 it is important to explore this relationship over an intervention using exercise as the 
known beneficial treatment for cLBP. If BMI is unrelated to or an unsuccessful predictor of changes 
in cLBP, it may be concluded that the measurement has little value in cLBP research and the reliance 
on BMI alone is unjustified. Therefore the aim of this study was to investigate the relationship 
between BMI and exercise-induced changes in pain and disability in patients with cLBP.   
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3.3 Methods 
 
3.3.1 Study design 
 
This was a retrospective, multi-centre study of patients who underwent 8-weeks of exercise-based 
treatment for cLBP. 
 
3.3.2 Patients  
 
One hundred and twenty eight (n=128; Table 3.1) patients from randomised controlled trials 
conducted at two rehabilitation clinics in Western Sydney, Australia, between 2011 and 2013 were 
included in the study. Patients were recruited through media and email advertising, letterbox drops 
and local leaflet distribution. Inclusion criteria were men and women aged 18 to 55 years with cLBP 
below the costal margin and above the gluteal fold lasting for a minimum of 12 consecutive weeks. 
Exclusion criteria were history of spinal surgery, diagnosed lumbar disc herniation or fracture, existing 
cardiac or nervous system condition, diagnosed mental illness, severe postural abnormality, pain 
radiating below the knee, diagnosed inflammatory joint disease or recent (<3 months) therapeutic 
treatment (eg. manipulation, mobilisation). 
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Table 3.1 Patient Demographics and 
Measurement Outcomes at Baseline 
(n=128) 
 
Age (y) 36.47 ± 7.73 
Height (m) 1.71 ± 0.09 
Weight (kg) 81.70 ± 15.40 
cLBP duration (y) 9.60 ± 7.14 
BMI (kg/m2) 27.82 ± 4.58 
VAS current pain (/100) 39.5 ± 22.7 
ODI score (%) 23.65 ± 11.68 
Pain subgroups 
     VAS: 0-44 (mm) 
     VAS: 45-100 (mm) 
 
74 
54 
Disability subgroups 
     ODI: 0-20 (%) 
     ODI >20 (%) 
 
59 
69 
PrExType 
     Core stability 
     Aerobic 
 
81 
47 
Data presented as mean±SD  
cLBP, chronic low back pain; BMI, body 
mass index; VAS, visual analogue scale; ODI, 
oswestry disability index; PrExType, 
predominant exercise type 
 
 
3.3.3 Procedures 
 
All patients were assessed for outcome measurements prior to and immediately after the exercise 
treatment program by blinded research assistants. Patients completed an 8-week exercise 
intervention after baseline assessment. The specific mode of exercise differed among patients, 
whereby 8 weeks of predominantly general aerobic exercise (eg. indoor stationary cycling) or 
predominantly core stability exercise (eg. trunk focused strength exercises and skilled contraction 
techniques) were performed. Three to five 1-hour exercise sessions (minimum of one supervised) per 
week of low-moderate intensity was required of all patients. Written informed consent was provided 
by patients prior to commencing the baseline assessment. 
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3.3.4 Outcome measurements 
 
Height and weight were measured using standardised procedures and calibrated equipment. Patients 
wore lightweight clothing with their shoes off. Weight was measured to the nearest 0.1kg and height 
to the nearest 0.1cm. BMI was calculated by dividing the patient’s weight by their height squared 
[weight(kg)/height(m)2].3 Self-reported current cLBP intensity was measured with a 100mm VAS,49, 53 
with the left anchor as “no pain” and the right anchor as “worst pain imaginable”.86, 199 Self-reported 
disability was measured with the ODI, a 10-item questionnaire resulting in a score out of 50 converted 
to a percentage49, 51, 53 The VAS and ODI are valid and reliable methods of measuring pain and 
disability in cLBP.199, 200  
 
3.3.5 Statistical analysis 
 
SPSS v20.0 (IBM Corp., 2011) was used for statistical analysis. Normal distribution of data was 
assessed using Kolmogorov-Smirnov and Shapiro-Wilk tests of normality, in addition to tests of 
skewness and kurtosis. Baseline BMI, VAS and ODI did not show major deviations from normal 
distribution, so the relationship between baseline BMI with self-reported pain and disability, as 
measured by VAS and ODI respectively, was explored using Pearson correlation coefficients. Multiple 
linear regression analyses were applied to examine the relationship between baseline BMI and 
changes in BMI with percentage changes in VAS and ODI (((post–baseline)/baseline)x100) resulting 
from exercise. The dependent variable was VAS or ODI percentage change and the independent 
variable was baseline BMI or changes in BMI, with covariates of predominant exercise type (general 
aerobic, core stability), cLBP duration, age and average number of exercise sessions per week.  
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A secondary analysis was performed to investigate the effect of baseline pain and disability levels on 
the primary regression analysis. This consisted of multiple linear regression analyses on separate pain 
or disability subgroups using baseline VAS and ODI scores respectively. The subgroups included no 
pain to mild pain (VAS:0-44mm), moderate to severe pain (VAS:45-100mm),201 no disability to 
minimal disability (ODI:0-20%), moderate disability (ODI:21-40%), severe disability (ODI:41-60%), 
crippling disability (ODI:61-80%) and bed-bound disability (ODI:81-100%).202-204 The dependent and 
independent variables and covariates were consistent with the primary regression analysis.  
 
While predominant exercise type was used as a covariate in all regression models, an analysis of 
covariance was performed to investigate the effect of predominant exercise modality (general 
aerobic or core stability) on BMI change. BMI change was the dependent variable, predominant 
exercise type was the between-subjects factor and average number of exercise sessions per week 
and baseline BMI were covariates. A final analysis was performed to examine whether clinically 
meaningful reductions (≥30% from baseline)205 in VAS or ODI could be predicted by baseline BMI. 
Likelihood ratios were used to determine if VAS and ODI changes were successfully predicted by 
baseline BMI. Cut-off values for BMI were established from commonly used ranges for overweight 
(25.0-29.9kg/m2) and obesity (≥30.0kg/m2).3, 78 Sensitivity (Sn), specificity (Sp) and likelihood ratios 
were then calculated, as described elsewhere,206 for clinically meaningful reductions in VAS and ODI 
with respect to BMI cut-offs. Sn and Sp values closer to 1 indicated a greater likelihood of a true 
positive or a true negative occurrence.207 Positive likelihood ratios (LR+) and negative likelihood ratios 
(LR-) above 10 and below 0.1 respectively indicated strong evidence to rule in or rule out a 
diagnosis.206, 208 Mean and SD were calculated for continuous variables. Only data collected at 
outcome assessments was included in statistical analysis. The significance level was set to p<0.05.    
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3.4 Results 
 
A total of n=128 patients were included in the study. Baseline outcome measurements are presented 
in Table 3.1. 54.7% (n=70) of patients had a BMI=25.0-29.9 and 22.7% (n=29) had a BMI≥30.0 at 
baseline. On the basis of pain sub-groups, n=74 patients reported a level of VAS=0-44mm and n=54 
patients reported a baseline pain level of VAS:45-100mm. On the basis of disability sub-groups, n=59 
patients reported a disability score of ODI:0-20% at baseline, n=59 reported a score of ODI:21-40% 
and a further n=8, n=2 and n=0 reported scores of ODI:41-60%, ODI:61-80% and ODI:81-100% 
respectively. Due to the small number of patients that reported baseline ODI>40%, the ODI:41-60%, 
ODI:61-80% and ODI:81-100% sub-groups were combined with the ODI:21-40% to form an ODI>20% 
sub-group of n=69 patients for analysis. Clinically meaningful reductions (≥30%)205 in VAS and ODI 
after exercise were experienced by 57.8% (n=74) and 46.9% (n=60) of patients respectively.  
 
3.4.1 Relationship between body mass index and self-reported pain and disability 
 
There were no significant correlations observed between baseline BMI and baseline VAS (r=-0.083, 
p=0.349) or baseline ODI (r=0.090, p=0.314). Baseline BMI was not related to changes in VAS (β=-
0.007, p=0.938) or ODI (β=0.015, p=0.873). Changes in BMI were also unrelated to changes in VAS 
(β=-0.077, p=0.402) or ODI (β=-0.017, p=0.854). 
  
Results of the secondary analysis showed no evidence of baseline relationships between BMI and VAS 
(r=-0.116, p=0.325; r=0.066, p=0.638) or ODI (r=0.092, p=0.436; r=0.160, p=0.247) when sub-grouped 
by VAS:0-44mm and VAS:45-100mm respectively. Similarly, baseline BMI was not related to changes 
in VAS (β=0.007, p=0.956; β=-0.097, p=0.493) or ODI (β=0.120, p=0.337; β=-0.083, p=0.560) when 
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sub-grouped by VAS:0-44mm and VAS:45-100mm respectively. Changes in BMI were also unrelated 
to changes in VAS (β=-0.111, p=0.373; β=0.014, p=0.922) or ODI (β=0.005, p=0.969; β=-0.032, 
p=0.822) when sub-grouped in the same manner. 
 
There were no baseline relationships found between BMI and VAS (r=-0.100, p=0.450; r=-0.146, 
p=0.230) or ODI (r=0.077, p=0.561; r=0.040, p=0.742) when sub-grouped by ODI:0-20% and ODI>20% 
respectively. Baseline BMI was not found to be related to changes in VAS (β=-0.085, p=0.578; 
β=0.042, p=0.730) or ODI (β=-0.091, p=0.536; β=0.118, p=0.335) when sub-grouped in the same 
manner. Changes in BMI were also unrelated to changes in VAS (β=-0.042, p=0.769; β=-0.097, 
p=0.433) or ODI (β=-0.098, p=0.484; β=-0.002, p=0.988) when sub-grouped by ODI:0-20% and 
ODI>20% respectively. Analysis of covariance showed that there was no significant effect of 
predominant exercise type on changes in BMI (p=0.459, 95%CI (-0.104, 0.228)). 
 
Prediction categorisation analyses based on clinically meaningful reductions (≥30%) in VAS and ODI 
with respect to baseline BMI are presented in Table 3.2 and Table 3.3 respectively. LR+ ranged from 
0.73 to 1.29 and 0.70 to 1.48 for VAS and ODI respectively, and LR- ranged from 0.73 to 1.09 and 0.63 
to 1.11 for VAS and ODI respectively.   
 
  
65 
 
  
Table 3.2 Prediction categorisation of clinically meaningful 
reductions in VAS on the basis of BMI 
BMI cut-off Sn  Sp LR+ LR- 
≥25.0 0.63 0.51 1.29 0.73 
≥30.0 0.19 0.74 0.73 1.09 
VAS, visual analogue scale; BMI, body mass index; Sn, sensitivity; 
Sp, specificity; LR+, positive likelihood ratio; LR-, negative 
likelihood ratio 
Table 3.3 Prediction categorisation of clinically meaningful 
reductions in ODI on the basis of BMI 
BMI cut-off Sn  Sp LR+ LR- 
≥25.0 0.65 0.56 1.48 0.63 
≥30.0 0.19 0.73 0.70 1.11 
ODI, oswestry disability index; BMI, body mass index; Sn, 
sensitivity; Sp, specificity; LR+, positive likelihood ratio; LR-, 
negative likelihood ratio 
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3.5 Discussion 
 
This is the first study to investigate the relationship between BMI and exercise-induced changes in 
self-reported pain and disability in cLBP patients. Although 77% of the patients were classified as 
overweight or obese, there was no evidence of a baseline relationship between BMI and pain or 
disability. No relationship was found between baseline BMI and changes in pain and disability 
following exercise. Moreover, changes in BMI were not related to exercise-induced pain and disability 
changes. It was also shown that baseline BMI did not predict clinically meaningful reductions in self-
reported pain and disability, despite 57.8% and 46.9% of patients experiencing such reductions in 
pain and disability respectively. The findings further showed that the likelihood of changes in pain 
and disability after exercise was not modified by BMI. The largest LR+ value was 1.20 and LR- was 
0.53, indicating only minimal effects on the probability of a clinically meaningful reduction in pain or 
disability, since ratios above 10 and below 0.1 are strong evidence to rule in or rule out a diagnosis 
respectively.206, 208 Based on the low-moderate Sn and Sp produced, the accuracy of the likelihood 
ratio results may be low. In addition, the lack of consideration for cut-off values in Sn and Sp analysis 
may have consequences associated with the incidence of false positive or false negative results, as 
was evident in the disparity of Sn and Sp values between a cut-off of BMI=25.0-29.9kg/m2 in 
comparison to BMI>30.0kg/m2. However, this is of little consequence since the overall modification 
of likelihood observed from LR+ and LR- was minimal. Consequently, these findings indicate that BMI 
alone may be of limited use as a predictor of pain and disability changes in cLBP.  
 
In consideration of these results, criticism of the BMI measurement in the past73, 80 may be valid. It 
could be suggested that BMI has been relied on too heavily in previous cLBP research and such 
reliance is unwarranted. Regardless of the evidence of a relationship between obesity and cLBP 
observed in earlier studies,76 the findings of this study and the inconsistencies of past research75 may 
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indicate that the use of BMI in cLBP research as a sole measure is not justified. The shift in research 
focus from obesity as a general concept to adipose tissue, in particular the distribution of adipose 
tissue, is further indication of the limitations of BMI as an obesity measurement. For example, 
adiposity has been linked to cLBP12,42 and may be significant in the pathogenesis of pain.80, 91-93 
Consequently, simplistic measurements of obesity such as BMI are seemingly inadequate and of little 
relevance to cLBP. No studies have yet examined the relationship between alternative obesity and 
adiposity measures, such as ultrasound-derived subcutaneous and visceral abdominal adipose tissue 
thickness, with pain and disability in cLBP patients. 
 
The results of this study suggest that exercise modality and the concomitant metabolic expenditure 
associated with each mode had no effect on BMI change, or the relationship between BMI change 
with pain and disability. It is possible that the 8-week exercise duration used in this study may not be 
sufficient to elicit BMI changes, since a dose-response relationship between exercise quantity and 
degree of weight loss has been previously suggested.209 Exercise dose has not been investigated in 
cLBP, and a greater frequency of sessions or duration of intervention may produce different results 
pertaining to the BMI-cLBP relationship.  However, consensus on exercise recommendations for 
inducing weight loss is lacking.30 Moreover, nutritional intervention may be of greater importance 
than the total exercise dose for inducing weight loss, as caloric restriction in combination with 
exercise is said to be more effective than exercise alone.31, 210 It must be considered that the exercise 
dose accrued in this study was sufficient to induce clinically meaningful reductions in pain and 
disability in 57.8% and 46.9% of patients respectively. The lack of an exercise modality effect on the 
relationship between BMI change with pain and disability suggests that research into a greater dose 
of exercise to elicit a BMI change may be of little relevance.  
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Due to the mild to moderate baseline level of pain and disability observed, the generalisability of 
findings may be limited to cLBP patients of the same pain or disability level. While possible that 
patients with increased pain or disability may have resulted in a relationship between BMI and cLBP, 
the generalisability of this study is strengthened by the sub-grouping analysis. The specific context of 
the study may also be a strength that previous research has lacked. For example, the 65 included 
studies of the aforementioned review included various body weight indices and an array of low back 
pain etiologies and definitions, ranging from acute to chronic conditions.75 Irrespective of the possible 
reduced generalisability, this study’s findings suggest that BMI is unrelated to cLBP, either at baseline 
or following an exercise intervention.  
 
  
69 
 
3.6 Conclusion 
 
BMI was not found to be related to changes in pain and disability in cLBP patients following eight 
weeks of exercise. Examination of likelihood ratios suggested that BMI is not a successful predictor 
of clinically meaningful reductions in pain and disability in cLBP. For this reason, the reliance on the 
BMI measurement of obesity in cLBP research may be unwarranted. Future research into cLBP should 
focus on alternative measurements of obesity to BMI. 
  
70 
 
Chapter 4: Relative Abdominal Adiposity is Associated with Chronic 
Low Back Pain: a Preliminary Explorative Study  
 
The text contained in this chapter was published in BMC Public Health in 2016.211 Please note that 
aspects of the published article have required modification to conform to the chapter-style thesis 
format, including citation numbers, headings, and formatting of tables and figures.  
 
4.1 Abstract 
 
4.1.1 Background 
Although previous research suggests a relationship between cLBP and adiposity, this relationship is 
poorly understood. No research has explored the relationship between abdominal-specific 
subcutaneous and visceral adiposity with pain and disability in cLBP individuals. The aim of this study 
therefore was to examine the relationship of regional and total body adiposity to pain and disability 
in cLBP individuals. 
 
4.1.2 Methods 
A preliminary explorative study design of seventy (n=70) adult men and women with cLBP was 
employed. Anthropometric and adiposity measures were collected, including body mass index, waist-
to-hip ratio, total body adiposity and specific ultrasound-based abdominal adiposity measurements. 
Self-reported pain and disability were measured using VAS and ODI questionnaires respectively. 
Relationships between anthropometric and adiposity measures with pain and disability were 
assessed using correlation and regression analyses.  
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4.1.3 Results 
Significant correlations between abdominal to lumbar adiposity ratio (A-L) variables and the WHR 
with self-reported pain were observed.  A-L variables were found to predict pain, with 9.1-30.5% of 
the variance in pain across the three analysis models explained by these variables. No relationships 
between anthropometric or adiposity variables to self-reported disability were identified. 
 
4.1.4 Conclusions 
The findings of this study indicated that regional distribution of adiposity via the A-L is associated with 
cLBP, providing a rationale for future research on adiposity and cLBP.  
 
4.1.5 Keywords 
Chronic low back pain, obesity, abdominal adiposity, ultrasound, pain, disability 
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4.2 Background 
 
cLBP places a large economic burden on society, with loss of income and treatment costs in Australia 
in excess of $9 billion annually.13 LBP affects 10% of the global population and is ranked as the 7th 
leading disability in the world and the highest ranked for years lived with the disability.26 Obesity is 
also a costly and prevalent health condition, which has been previously linked to cLBP.23, 71-80 In the 
past this relationship has been demonstrated using BMI as a measure of obesity,71, 74, 76, 78, 139 which 
has been defined as an individual’s body weight divided by their height squared.3 Despite its common 
use, the simplicity of BMI and its disregard for body composition80 have led to its criticism and greater 
emphasis on alternative obesity measurements. This shift in focus is important because research 
suggests that adipose tissue may be of consequence in the pathogenesis of chronic pain conditions.80 
For example, increased adiposity (total body, upper and lower limbs, trunk, android and gynoid) is 
associated with higher levels of LBP intensity and disability.80 US may be a suitable substitute for BMI 
and other simplistic obesity measurements as it is a valid and reliable measurement tool of assessing 
adiposity when compared to gold standard methods.32, 90, 182-184, 186 However, US has not yet been 
utilized in cLBP research. 
 
Although there is an established relationship between adiposity and LBP,80 the inconsistent and 
poorly defined terminology used in the past makes previous research confusing and difficult to draw 
conclusions from. Moreover, there is a lack of research on the distribution of adiposity and its possible 
relationship with pain and disability levels in cLBP. No studies have investigated whether regionally 
accumulated abdominal adiposity may be of more relevance than total body adiposity in a cLBP 
population. For example, visceral adiposity has been suggested to be more important than total 
adiposity in the risk of developing obesity-related disorders.89, 90 Visceral adiposity has also been 
suggested to be of greater consequence to the metabolic profile32, 195 and various medical 
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pathologies88 than subcutaneous adipose tissue, on the basis of physiological and metabolic 
differences such as adipocyte size and lipolytic activity.196 It may then be suggested that the 
distribution of excess visceral adipose tissue could also be associated with increased pain in cLBP 
individuals. Several plausible mechanisms for a cLBP-visceral adiposity relationship exist, including 
inflammatory processes occurring from adipose tissue or increased mechanical load on the lumbar 
spine and surrounding structures produced by excess adiposity.80 However, the cLBP-obesity 
relationship remains largely unknown, since research on the relationship between adiposity, 
primarily visceral, and cLBP is lacking. 
 
In the exploration of the relative importance of regional versus total body adiposity, it is reasonable 
to believe that greater accumulation of adipose tissue in the abdominal region when compared to 
the lumbar region may also be of significance in the relationship to pain and disability in cLBP. This 
abdominal to lumbar adiposity ratio may be important, as greater abdominal adiposity could have 
flow-on effects for cLBP sufferers beyond that of an increase in body weight. For example, increased 
abdominal adipose tissue may result in the adoption of a compensatory hyperlordotic posture to 
counteract the constant anterior flexion torque placed on the lumbar spine. This excess anterior mass 
is worthy of investigation, as such an increase in compressive force may predispose the spine to 
injury.163 Irrespective of the potential metabolic or biomechanical mechanisms that may be 
responsible for such a relationship, the parameters of a possible association between adiposity and 
cLBP should first be examined.  
 
As a result of the inconsistencies of previous research and the potentially important consequences of 
visceral adiposity on the persistence of cLBP via metabolic factors such as the stimulation of 
inflammatory processes, it is warranted to examine the significance of adiposity distribution and 
particularly visceral adiposity on the obesity-cLBP relationship. US may then be employed to 
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investigate the possible importance of visceral adipose tissue, since it has been shown to be a valid 
and reliable method of assessing abdominal adiposity.32, 90, 182-184, 186 Therefore, the aim of this study 
was to examine the relationship between regional and total body adiposity with pain and disability in 
cLBP individuals. The experimental objectives of this study were: 1) To use US-derived ratios to assess 
abdominal adipose tissue distribution in individuals with cLBP, 2) To perform correlation and 
regression analyses to examine relationships between anthropometric and adiposity variables with 
self-reported pain and disability in cLBP individuals, and 3) To perform the correlation and regression 
analyses on pain and disability subgroups within the cLBP dataset. The hypothesis of this study was 
that greater abdominal adiposity, particularly visceral, would be associated with increased self-
reported pain and disability in a cLBP population.  
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4.3 Methods 
 
4.3.1 Study design 
 
A preliminary explorative study design was employed to examine the relationship between adiposity 
distribution with pain and disability in a cLBP population. All participant data was collected at a 
tertiary education facility in Western Sydney, Australia, over a three-year period with two cycles of 
participant recruitment and data collection. 
 
4.3.2 Study population 
 
Seventy (n=70) adult men and women aged 18-76 years were included in the study and were 
recruited through the use of media advertising and leaflet drops in the local area. All included 
participants had cLBP (pain between the costal margin and gluteal fold for a minimum of three 
months). Participants were excluded if they had a history of spinal surgery, spinal fracture, diagnosed 
lumbar disc herniation (and attained a positive result on the straight leg raise test), existing bone, 
cardiac or nervous system condition, diagnosed severe mental illness, severe postural abnormality, 
pain radiating below the knee or diagnosed inflammatory joint disease. Written informed consent 
was provided by all participants. This study had ethical approval for research on human subjects by 
the Human Research Ethics Committee review board on the basis of the Declaration of Helsinki.  
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4.3.3 Anthropometric measures 
 
Height, weight, WC and hip circumference were measured while participants were barefoot and 
wearing lightweight clothing. Height was measured using a wall-mounted stadiometer (Veeder-Root 
high speed counter, Elizabethtown, N.C.) and recorded to the nearest 0.1cm. Weight was measured 
using a calibrated digital scale (A&D UC-321, A&D Co., Ltd) and recorded to the nearest 0.1kg. Waist 
circumference was measured using an anthropometric tape measure (Lufkin Executive Diameter 
Pocket Tape W606PM) at the narrowest point between the costal margin and the iliac crest and 
recorded to the nearest 0.1cm. Hip circumference was measured at the widest point of buttocks 
approximately level with the greater trochanters of the femur and recorded to the nearest 0.1cm. 
BMI and WHR were then calculated as weight divided by height squared (kg/m2)3 and WC divided by 
hip circumference, respectively.  
 
4.3.4 Adiposity measures 
 
4.3.4.1 Total body adiposity 
 
Total body adiposity was measured using BIA (Metagenics VLA50, variation of ImpDF50, ImpediMed 
Limited, Eight Mile Plains, QLD, 2005), which has been shown to be a valid and reliable method when 
compared to gold standard methods.33-36, 173, 176, 178, 179 Participants were required to refrain from food, 
drink and exercise 2 hours prior to the test and avoid alcohol in the 12 hours prior. Immediately prior 
to the test, participants emptied their bladder and lay supine on a plinth for 5 minutes to stabilise 
body fluids. The participant remained in this position with arms by their sides for the duration of the 
test. Pairs of electrodes (Ag/AgCl 3cm diameter, Kendall Medi-Trace 100, Tyco Healthcare Group LP, 
Mansfield, MA) were placed on their hand and foot on the right side of the body. Prior to electrode 
placement, the skin was adequately prepared using a safety razor, fine abrasion tape and alcohol 
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swabs to remove excess hair and reduce impedance. The hand electrodes were placed between the 
radial and ulna styloid processes 1cm proximal to the metacarpophalangeal joint of the middle finger. 
The foot electrodes were placed between the medial and lateral malleoli of the tibia and fibula, 
respectively, and 1cm proximal to the metatarsophalangeal joint of the middle toe. Each electrode 
pair was a minimum of 10cm apart. Resistance and reactance was recorded from the BIA device and 
then used to calculate total body adiposity percentage from the BIA software. 
 
4.3.4.2 Regional adiposity  
 
Regional adiposity (including lumbar, supra-iliac and multiple abdominal sites) was measured with US 
using previously validated and reliable methods.32 Five subcutaneous adiposity and two visceral 
adiposity measurements were conducted over six anatomical locations on the surface of the skin in 
the trunk region of each participant, of which five have been described elsewhere.32 Details and 
images of each measurement are listed in Table 4.1 and shown in Figures 4.1 and 4.2 respectively. 
Participants were required to lie supine for a period of 10 minutes prior to US testing to allow body 
fluids to stabilise. Each measurement required the use of conductive gel to gain a clear image.  
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Table 4.1 Ultrasound measurements  
Measurement Probe Anatomical location Method used for measurement 
msA Linear  
Just below the xiphoid process 
of the sternum 
Minimum distance between the 
fat-skin barrier and the anterior 
surface of the linea alba 
MppA Linear  
Just below the surface of the 
xiphoid process of the sternum 
(same anatomical position as 
the minimum subcutaneous 
adiposity measurement) 
Maximum distance between the 
posterior surface of the linea alba 
and the anterior surface of the 
peritoneum covering the liver 
MsA Linear  
(A) 2cm above the umbilicus 
and (B) 2cm below the 
umbilicus 
Maximum distance in the centre of 
the image between the fat-skin 
barrier and the anterior surface of 
the linea alba 
MiA Convex  
2cm above the umbilicus 
(same anatomical position as 
the maximum subcutaneous 
abdominal adiposity A 
measurement) 
Maximum distance in the centre of 
the image between the posterior 
surface of the rectus abdominis 
muscle and the anterior wall of the 
abdominal aorta 
MsSI Linear 
Just above the iliac crest on 
the mid-axillary line 
Maximum distance between the 
fat-skin barrier and the anterior 
surface of the external oblique 
muscle 
MsL Linear 
Level of L4/L5 directly over the 
lumbar erector spinae muscle 
Maximum distance between the 
fat-skin barrier and the anterior 
surface of the lumbar erector 
spinae muscle 
msA, minimum subcutaneous abdominal adiposity; MppA, maximum pre-peritoneal abdominal 
adiposity; MsA, maximum subcutaneous abdominal adiposity; MiA, maximum intra-abdominal 
adiposity; MsSI, maximum subcutaneous supra-iliac adiposity; MsL, maximum subcutaneous 
lumbar adiposity 
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Figure 4.1 Examples of abdominal US measurements (i) minimum subcutaneous abdominal adiposity (ii) 
maximum pre-peritoneal abdominal adiposity (iii) maximum subcutaneous abdominal adiposity A (iv) 
maximum subcutaneous abdominal adiposity B 
 
 
Figure 4.2 Examples of intra-abdominal, supra-iliac and lumbar US measurements (v) maximum intra-abdominal 
adiposity (vi) maximum subcutaneous supra-iliac adiposity (vii) maximum subcutaneous lumbar adiposity 
 
(i) 
(ii) 
(iii) (iv) 
(v) 
(vi) (vii) 
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4.3.4.3 Adiposity ratios 
 
The adiposity ratios calculated from ultrasound-derived adiposity thickness measurements are 
defined in Table 4.2, of which one has been previously described.32 Such ratios were worthy of 
inclusion as past research has questioned simplistic anthropometric measurements such as BMI and 
WHR due to their lack of sensitivity and specificity.80, 212, 213 Additionally, existing evidence implies a 
relationship between adiposity and pain that may be complex and multifactorial.80 Consequently, the 
examination of adiposity relative to the individual may be crucial to better understanding the 
relationship between adiposity and cLBP.  
 
Table 4.2 Ultrasound-derived adiposity variables 
Measure Calculation Definition 
A-L (MsAa + MiA) / MsL 
Abdominal-to-lumbar adiposity ratio (subcut. + visc. 
abdo measures for total abdominal adiposity 
thickness relative to lumbar adiposity thickness) 
S-M (MsAa + MsSI + MsL) / weight 
Subcutaneous adiposity to mass ratio (total 
subcutaneous trunk adiposity thickness relative to 
overall body mass)  
V-M 
 
(MppA + MiA) / weight 
Visceral adiposity to mass ratio (total visceral trunk 
adiposity thickness relative to overall body mass)  
MAR-A 
 
MsAa / MiA 
Maximal abdominal ratio A (ratio between 
subcutaneous and visceral abdominal adiposity) 
A-L/BMI 
 
[(MsAa + MiA) / MsL] / 
[weight / (height x height)] 
Abdominal-to-lumbar adiposity ratio relative to BMI 
(ratio between abdominal and lumbar adiposity 
thickness relative to overall body mass index 
A-L/WHR 
 
[(MsAa + MiA) / MsL] /  
(waist circumference /  
hip circumference) 
Abdominal-to-lumbar adiposity ratio relative to WHR 
(ratio between abdominal and lumbar adiposity 
thickness relative to the ratio between waist and hip 
circumferences) 
TC-TBF 
 
(MsAa + MsSI + MsL) / total 
body adiposity percentage 
Total circumference relative to total body adiposity 
ratio (total trunk circumference adiposity thickness 
relative to total body adiposity percentage) 
MppA, maximum pre-peritoneal abdominal adiposity; MsAa, maximum subcutaneous 
abdominal adiposity A; MiA, maximum intra-abdominal adiposity; MsSI, maximum 
subcutaneous supra-iliac adiposity; MsL, maximum subcutaneous lumbar adiposity 
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4.3.5 Pain and disability 
 
Self-reported pain was measured using a VAS, with ‘no pain’ on the left anchor and ‘worst pain 
imaginable’ on the right anchor, whereby the participant rated their current cLBP on a 100mm line.199, 
214 Self-reported disability was measured using the ODI questionnaire, whereby participants filled in 
a 10-item questionnaire that was scored and converted to a percentage.86, 199, 214 VAS and ODI have 
been previously shown to be valid and reliable methods of measuring self-reported pain and disability 
respectively in pain research, including cLBP populations.200, 203, 215-218 
 
4.3.6 Statistical analysis 
 
Statistical analyses were performed using SPSSv23 (IBM Corp., 2015). Mean and standard deviation 
were presented for characteristics of the study sample. Normal distribution of data was assessed by 
Kolmogorov-Smirnoff and Shapiro-Wilk tests, and examination of Q-Q plots, frequency histograms 
and standard errors of skewness and kurtosis. Variables not normally distributed were log 
transformed and parametric methods of analysis were then used. Three (3) datasets were used for 
statistical analysis; the total sample of participants (n=70) to avoid the potential for detection bias, a 
VAS subgroup with a minimum level of pain as indicated by 2.0 or greater on the VAS scale (n=42), 
and an ODI subgroup with a minimum level of disability as indicated by 10.0% or greater on the ODI 
questionnaire (n=52). Pearson correlation coefficients were used to identify relationships between 
anthropometric and adiposity variables with self-reported pain and disability. Stepwise regression 
analyses were performed to explain relationships between anthropometric and adiposity variables 
with pain and disability, as well as determine the proportion of variance in pain and disability 
explained by such variables. Adjusted R square values were reported for significant relationships. 
Predictor variables included in the regression analysis were determined by the results of the 
correlation analysis, where only variables found to be correlated with pain or disability were included 
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in the regression models to reduce the potential effect of confounding variables. The variance 
inflation factor (VIF) was used to determine the effect of collinearity of prediction variables on 
regression analyses. A VIF>5 for any two variables was used to indicate collinearity, in which case the 
variable with the higher VIF was removed from the prediction model. Missing data were addressed 
through exclusion of the incomplete variable/s for a given participant from the analysis model. The 
study size was arrived at with the use of post-hoc calculations of statistical power. Statistical 
significance was set at p<0.05. 
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4.4 Results 
 
A total of n=122 individuals were screened for inclusion and n=70 cLBP individuals were eligible and 
chose to participate in the study. The characteristics of the study sample are summarised in Tables 
4.3-4.5. One participant had missing data of the minimum subcutaneous lumbar adiposity 
measurement. 
 
  
Table 4.3 Demographic characteristics of the study sample (n=70) 
 
Age (yrs) 39.57 ± 11.01 
cLBP (yrs) 9.84 ± 8.60 
Gender (M/F) 30M, 40F 
Height (m) 1.70 ± 0.08 
Weight (kg) 79.66 ± 17.44 
BMI (kg/m2) 27.49 ± 5.63 
WC (cm) 87.72 ± 14.68 
HC (cm) 104.94 ± 10.03 
WHR 0.83 ± 0.09 
%TBF 29.99 ± 10.87 
ODI 16.66 ± 9.65 
VAS 2.38 ± 1.78 
Data mean ± SD; cLBP, chronic low back pain; BMI, body mass index; 
WC, waist circumference; HC, hip circumference; WHR, waist-to-hip 
ratio; %TBF, total body adiposity percentage; ODI, oswestry 
disability index; VAS, visual analogue scale 
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Table 4.5 Relative ultrasound measurements and ratios of the study sample (n=70) 
 
A-L 12.42 ± 9.12 
S-M 0.54 ± 0.24 
V-M 0.78 ± 0.20 
MAR-A 0.46 ± 0.25 
A-L/BMI 0.47 ± 0.38 
A-L/WHR 14.44 ± 10.11 
TC-TBF 1.44 ± 0.52 
Data mean ± SD; A-L, abdominal to lumbar adiposity ratio; S-M, subcutaneous 
adiposity to mass ratio; V-M, visceral adiposity to mass ratio; MAR-A, maximum 
abdominal ratio A; A-L/BMI, abdominal to lumbar adiposity ratio relative to BMI; A-
L/WHR, abdominal to lumbar adiposity ratio relative to WHR; TC-TBF, total 
circumference relative to total body adiposity ratio 
 
 
  
 
Table 4.4 Absolute ultrasound measurements (mm) of the study sample (n=70) 
 
msA 12.34 ± 7.79 
MppA 13.36 ± 4.53 
MsAa 20.19 ± 9.69 
MsAb 19.60 ± 9.90 
MiA 49.77 ± 23.01 
MsSI 14.40 ± 7.69 
MsL 8.36 ± 6.90 
Data mean ± SD; msA, minimum subcutaneous abdominal  adiposity ; MppA, 
maximum pre-peritoneal abdominal  adiposity ; MsAa, maximum subcutaneous 
abdominal  adiposity A; MsAb, maximum subcutaneous abdominal  adiposity B; 
MiA, maximum intra-abdominal  adiposity ; MsSI, maximum subcutaneous 
supra-iliac  adiposity ; MsL, maximum subcutaneous lumbar  adiposity 
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4.4.1 Relationship between anthropometric and adiposity measures to pain and 
disability 
 
Correlations between anthropometric and adiposity measures with pain are shown in Table 4.6. 
There were no significant correlations observed between self-reported disability and anthropometric 
or adiposity variables in any of the analysis models. ODI was found to be correlated to VAS in the total 
sample (r=0.264, p=0.028), but not in either of the subgroup analysis models. 
 
Stepwise regression showed that 9.1% (p=0.007) of the variance in pain was explained by A-L alone 
in the total sample analysis (n=70), which was increased to 15.7% (p=0.001) when ODI was added to 
the model. Results of the stepwise regression for the VAS subgroup indicated that 30.5% of the 
variance in pain could be explained by A-L relative to WHR (A-L/WHR, p<0.001). Similar results were 
observed in the ODI subgroup regression analysis, as 24.7% of the variance in pain was explained by 
A-L relative to BMI (A-L/BMI, p<0.001). No regression analysis was performed on self-reported 
disability on the basis of no significant correlations to anthropometric or adiposity variables in any of 
the analysis models. Post-hoc results revealed an achieved statistical power of β=0.75 for the variance 
in pain explained by A-L/WHR.  
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Table 4.6 Significant correlations between anthropometric and adiposity 
variables with self-reported pain 
 
Analysis model Variable r p 
Total sample (n=70) 
A-L 0.323 0.007 
A-L/WHR 0.315 0.008 
A-L/BMI 0.303 0.011 
VAS subgroup (n=42) 
A-L 0.566 <0.001 
A-L/WHR 0.568 <0.001 
A-L/BMI 0.546 <0.001 
ODI subgroup (n=52) 
A-L 0.493 <0.001 
A-L/WHR 0.438 0.001 
A-L/BMI 0.5111 <0.001 
WHR 0.287 0.039 
VAS, visual analogue scale; ODI, oswestry disability index; A-L, abdominal 
to lumbar adiposity ratio; A-L/WHR, abdominal to lumbar adiposity ratio 
relative to WHR; A-L/BMI, abdominal to lumbar adiposity ratio relative to 
BMI; WHR, waist-to-hip ratio 
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4.5 Discussion 
 
It was hypothesised that greater abdominal adiposity, particularly visceral, would be associated with 
increased self-reported pain and disability in cLBP individuals. This study’s findings showed a 
relationship between anthropometric and adiposity measures to self-reported pain in cLBP, but not 
disability. More specifically, A-L relative to the size of the individual was the best predictor of self-
reported pain.  
 
The results of this study support previous suggestions that visceral adiposity may be more important 
than subcutaneous adiposity in the relationship to pain. For example, the overflow of adipocytes into 
excess visceral and ectopic stores may initiate a process of metabolic dysfunction91 resulting from the 
disrupted equilibrium between energy intake and lipid oxidation.213 Consequently, this overflow may 
promote the release of adipocyte-derived pro-inflammatory cytokines93 contributing to insulin 
resistance and end-stage disease,91, 93 but also to hyperalgesia and central sensitisation.92 In addition 
to metabolic dysfunction, there is growing evidence for the pathophysiological consequences on 
bone and skeletal muscle integrity and function from abnormal lipid accumulation.213 The result may 
then be chronic low-grade systemic inflammation91, 93 and therefore the persistence of a chronic pain 
state.92 For example, increased levels of CRP, a sensitive acute-phase protein associated with body 
adiposity measures,219 has been linked to greater odds of reporting LBP symptoms, particularly in 
those measured as obese by BMI or WC.219 It has been suggested that increased CRP may be indicative 
of early signs of low-grade chronic systemic inflammation.219 Consequently, it may validate the 
implication of pro-inflammatory cytokines in the complex pathways of musculoskeletal pain219 and 
further support the use of visceral adiposity measurements, such as US, in the research of cLBP and 
other chronic pain pathologies.  
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This study’s findings may also support a theorised metabolic mediation in the adiposity-pain 
relationship.80 Since pain was found to be significantly correlated with A-L relative to BMI or WHR, 
visceral adiposity relative to body size and shape may be an important consideration for future 
research. For example, the distribution of A-L may be just as important as the overall representation 
of body size and mass distribution. Therefore, it may be the accumulation of body mass coupled with 
greater levels of relative adiposity that puts an individual in an increased or more persistent cLBP 
state.  
 
The moderate to strong correlations and prediction models between pain and A-L relative to WHR 
and BMI may advocate a possible physiological or biomechanical mediation between obesity and 
cLBP. For instance, WHR measures an individual’s anatomical circumference of the waist compared 
to the hips to assess adiposity distribution220 and the associated risk of deviating from optimal body 
morphology for physical health. In turn, BMI is a measure of overall body size as a relative association 
between height and weight,3 with an optimum balance to achieve the ‘healthy’ range. Consequently, 
coupling WHR and BMI with the A-L/pain relationship may further support a physiological or 
biomechanical mediation. It is reasonable to believe that the body can only manage a degree of 
anterior-to-posterior load, but is also functionally limited by waist-to-hip load and overall body load. 
For example, perhaps an individual with a high A-L, large WHR and elevated BMI may be in greater 
pain than someone with the same A-L but lower WHR and BMI. It may be the accumulation of the 
overall body mass and weight distribution including adiposity that acts as a pain catalyst, but is the 
A-L that is most instrumental in observable and measurable biomechanical changes. For instance, it 
is plausible that greater anterior mass may result in increased compensatory lordosis during normal 
daily posture, manifest by spinal hyperextension, and thereby excess abdominal adiposity may result 
in increased magnitude or repetition of compression loading, which is a known precursor for risk of 
intervertebral disc injury.163 Moreover, previous research suggests that both vertebral joint 
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compression and postural deviation may impact upon shear injury potential.164 Irrespective of these 
yet unconfirmed inferences, it is known that obesity and cLBP are linked23, 71-80 and that simplistic 
measurements like BMI are unrelated to cLBP197 and lack the sensitivity to detect excessive adiposity 
in non-obese individuals.213 Therefore, future research may need to explore more comprehensive 
measurements such as A-L to further quantify and explain the adiposity-cLBP relationship.  
 
The hypothesis that greater abdominal adiposity would be associated with increased disability was 
not supported, as no correlations were found between anthropometric and adiposity variables with 
disability. This finding was not supported or refuted by previous research, since no other studies to 
the authors’ knowledge have examined the relationship between adiposity and disability associated 
with cLBP. An earlier study reporting a relationship between adiposity and disability associated with 
LBP80 was not specific to cLBP and assessed adiposity and disability using different methods to those 
used in this study. Therefore, further research may be necessary to confirm that adiposity and 
disability are unrelated in cLBP.  
 
The novelty of this research lends itself to potential constraints, such as the use of absolute and 
relative adiposity ratios not previously studied. The removal of variables to eliminate collinearity 
during statistical analysis may have excluded potentially relevant variables from the prediction 
models. However, any variables removed were those with the least impact on the prediction models. 
Correlation analysis between each variable with pain and disability also ensured all relevant 
relationships between variables were explored. It may be irrelevant which A-L variables were left in 
the regression analyses, since all A-L variables were found to have strong correlations to pain. The 
use of WHR instead of WC may be a limitation since adipose tissue deposits in the abdominal versus 
gluteofemoral region may have different biological mechanisms and therefore altered health risk 
implications.220 For this reason, future studies into the A-L/cLBP relationship may benefit more from 
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the use of WC instead of WHR. The selection of VAS and ODI cutoff values may have excluded 
potentially relevant data, but since the majority of existing research explored the minimum level of 
clinically meaningful change over time no previous consensus on normative scores for minimal pain 
or disability levels in cLBP was found. Therefore, values were set from collaborative evidence of 
minimal important change values in VAS ranging from 1.5-2.0205 and a normative score of 10.19 for 
ODI of ‘normal’ populations,203 which was deemed appropriate based on available evidence. The 
study results can only be generalised to adult cLBP populations. 
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4.6 Conclusions 
 
The results of this study demonstrated significant relationships between abdominal adiposity and 
cLBP. A-L combined with increased WHR and BMI was a predictor of pain variance. Therefore, an 
individual’s adiposity distribution relative to their body or trunk mass may be of greater importance 
in the cLBP-obesity relationship than single measurements alone. These findings support the use of 
US-based methodologies for future cLBP research. Until the mechanisms responsible for the 
adiposity-cLBP relationship are better understood, attempts to manipulate it through pain or 
adiposity reduction treatment may be of little benefit. For this reason, additional research into 
possible physiological, metabolic and biomechanical mediators between adiposity distribution and 
pain manifestation in cLBP is warranted.  
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Chapter 5: What Explains Task Performance? An Exploration of 
Relationships Between Relative Abdominal Adiposity, Lumbar Muscle 
Endurance, Pain Development and Task-induced Lumbar Flexion in 
cLBP Individuals Performing the Biering-Sorensen Test 
 
5.1 Introduction 
 
The Biering-Sorensen test is a common postural task for assessing lumbar muscle endurance,221 which 
requires an individual to hold their upper body in an unsupported horizontal position.221-224 This 
position is maintained for a specified time period or until volitional exhaustion.221, 225 It has been 
shown that people with cLBP exhibit shorter task duration times compared to healthy asymptomatic 
individuals.221, 224 While mechanisms of fatigue and reasons for task failure during the Sorensen test 
have been previously studied,224, 226, 227, 228, 229 past research lacks consideration of body mass 
distribution and its potential effect on task performance. Body mass distribution may be of relevance 
and importance to the Sorensen test, due to the possibility that abdominally-accumulated adiposity 
may contribute to pain provocation and consequently test cessation. For example, the mechanical 
load on the lumbar spine and surrounding structures (ligaments, tendons, muscles) from excess 
anterior mass80 may increase back pain experienced and reported during the test, and lead to 
premature test cessation. This possibility is supported by the previous work of the author (see 
Chapter 4), which identified a relationship between anthropometric and adiposity measures to self-
reported cLBP.211 More importantly, an individual’s A-L relative to the regional and overall size of the 
individual was found to be a significant predictor of pain.211 It has been suggested that the human 
body may be restricted by certain tolerable levels of anterior-to-posterior loading, in addition to that 
of the overall body size and regional waist-to-hip load.211 Moreover, deviations from this tolerated 
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loading may be observed through pain responses, whereby correlations between pain and relative A-
L may indicate an underlying physiological or biomechanical mediation between adiposity and 
cLBP.211 For instance, cLBP individuals with larger A-Ls may exhibit poorer Sorensen performance and 
greater pain development than those with lower A-Ls.  
 
Moreover, Sorensen duration may be moderated by body mass distribution through its influence on 
spinal extensor muscle fatigue, which refers to the decline of a muscle or muscle group to generate 
force or power.230 In the context of the Sorensen test, muscle fatigue indicates an inability of the 
lumbar muscles to continue producing sufficient force to maintain the required horizontal position. 
In cLBP populations, it has been suggested that they may adopt varying neuromuscular strategies, 
possibly moderating back extensor muscle fatigue.231 If cLBP individuals are already at a 
predisposition to greater paraspinal fatigue as previous research suggests,221, 227, 228, 232 it is plausible 
that those with increased A-Ls may exhibit shorter Sorensen duration than those with more 
favourable body morphology. Therefore, adipose tissue distribution such as the A-L may initiate a 
muscle recruitment strategy that explains Sorensen task performance. For example, a study on male 
construction workers found those with a definite low back disorder used a higher percentage of 
maximum trunk extensor strength during the test, compared to those with probable or no history of 
low back disorder.233 Although it only accounted for 8% of the variability233 and the study population 
was not clearly identified as having cLBP, it may suggest that people with LBP have increased lumbar 
muscle recruitment that predisposes them to more rapid fatigability. Therefore, it may be reasonable 
to believe that body mass distribution is the missing link to different neuromuscular strategies in 
cLBP. 
 
Another consideration may be a link between paraspinal muscle fatigue and task-induced flexion of 
the lumbar spine. Previous studies have shown that lumbar flexion may coincide with LBP, reductions 
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in lumbar muscle endurance94 and excessive activation of spinal extensor muscles leading to 
increased tissue strain.95 Research suggests that those with a ‘flexion pattern’ pain disorder exhibit 
greater flexion and rotation of the lumbar spine compared to those without cLBP, as well as 
compensatory adjustments to trunk muscle contraction as a reflex pain response.95 In a study on 
healthy individuals, a lower rate of paraspinal muscle fatigue and longer task duration times were 
observed in a modified version of the Sorensen test compared to the original.231 The authors 
attributed the disparity to increased thoracolumbar fascia contribution, resulting from greater hip 
extensor muscle stretch in the modified test. However, they also raised the need for investigation of 
the potential relationship between lordotic curvature and paraspinal muscle fatigue.231 It may be 
possible for increased abdominal adipose tissue to induce greater task-specific lordotic curvature 
(manifest by spinal flexion), which has been associated with the presence of LBP and reduced lower 
back muscle endurance.94 This reduction in muscular endurance may result from the increased 
activation of lumbar muscles to compensate for the acute spinal movement. Such a theory is 
supported by the knowledge that activities largely involving the counteraction of gravity are 
associated with increased fatigability in people with obesity, due to greater force production 
requirements.169 Additionally, research shows that BMI has a negative effect on lumbar paraspinal 
muscle fatigability in both genders, mainly at the L4-L5 level and particularly in women.234 Since no 
studies have yet examined the effect of body mass distribution on Sorensen test performance in cLBP, 
such propositions are yet to be confirmed. One previous study on construction workers with and 
without LBP233 measured the torque of trunk weight, which was calculated by the distance between 
the anterior superior iliac spine and the centre of the shoulder joint. They then explored the 
relationship to isometric trunk muscle endurance using the Sorensen test. No significant correlation 
between torque of trunk weight and endurance time was identified.233 However, they did not control 
for body mass distribution between the two populations tested.  
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Previous research has established that obesity has negative consequences on muscle fatigue169, 234 
and that relative adiposity is related to cLBP,211 yet no studies have explored the effect of adiposity 
distribution on the Sorensen test. Moreover, it remains unknown if body mass and adiposity 
distribution is associated with task performance, and if so whether this relationship can be explained 
by spinal movement or lumbar muscle fatigue. For this reason, the objective of this study was to 
examine relationships between relative abdominal adiposity, lumbar muscle endurance, self-
reported pain development and lumbar spinal flexion with Sorensen test duration time in cLBP. It was 
hypothesised that increased body mass and abdominally-accumulated adiposity would be associated 
with shorter task duration times, and that this association would be explained by increased spinal 
flexion and faster rates of muscle fatigue.  
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5.2 Methods 
 
5.2.1 Study design 
A cross-sectional study was used to examine the effect of abdominal mass distribution on the Biering-
Sorensen test in cLBP individuals. All data was collected in a university laboratory setting. 
 
5.2.2 Participants 
Fifty-two (n=52) adults with cLBP were included in the study. Participants were recruited through the 
use of local newspaper advertising and leaflet distribution. The study included men and women aged 
18 to 55 years, with cLBP below the costal margin and above the gluteal fold lasting for a minimum 
of 12 consecutive weeks. Individuals were excluded from the study if they had undergone previous 
spinal surgery, had a diagnosed structural issue (eg. lumbar disc herniation), existing cardiac or 
nervous system condition, or a history of diagnosed mental illness (eg. depression). Written informed 
consent was received from all participants prior to testing. Ethical approval was granted by the 
University Human Research Ethics Committee on the basis of the Declaration of Helsinki. 
 
5.2.3 Procedure 
A single testing session was required for each participant in the study, in which anthropometric and 
adiposity outcome measures were assessed, including weight, BMI, WC, WHR, %TBF, and relative 
abdominal adiposity variables. Self-reported pain and disability were also recorded. Each participant 
then performed the Biering-Sorensen test of lumbar endurance. 
 
5.2.3.1 Biering-Sorensen test 
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Each participant was required to lie prone on a plinth with the level of the superior border of the iliac 
crest at the edge of the plinth and their legs secured by straps, as used elsewhere.221 The straps were 
placed around the lower portion of the gastrocnemius muscles and across the hamstrings inferior to 
the gluteal fold, with folded towels used under the ankles for improved comfort. During the test, 
individuals were required to keep their arms folded across their chest with their hands touching 
opposite shoulders and to maintain their upper body in an unsupported isometric horizontal position 
for ‘as long as possible’. The participant’s upper body position was monitored throughout the test 
and prompts were provided when necessary for position correction. Test termination criteria 
included an inability of the participant to continue to maintain the correct horizontal position for five 
consecutive seconds, or due to volitional exhaustion. Sorensen duration time was recorded by a 
stopwatch as the time from commencement to termination. Prior to the commencement of the test, 
participants were given a five-second practise hold for familiarisation. 
 
5.2.4 Outcome measurements 
5.2.4.1 Anthropometric measurements 
 
Height, weight and WC were measured while participants were barefoot and wearing lightweight 
clothing. Height was measured with a wall-mounted Veeder-Root high speed counter stadiometer to 
the nearest 0.1cm. Weight was recorded from an A&D calibrated digital scale to the nearest 0.1kg. 
WC was measured at the narrowest point between the costal margin and the iliac crest212 to the 
nearest 0.1cm. Hip circumference was measured at the widest point of the buttocks212 approximately 
level with the greater trochanters of the femur, and was recorded to the nearest 0.1cm. BMI was 
calculated as weight divided by height squared (kg/m2).3 WHR was calculated as WC divided by hip 
circumference.104 
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5.2.4.2 Total body adiposity  
 
%TBF was measured using an ImpediMed BIA system, shown to be valid and reliable compared to 
gold standard methods.33-36, 173, 176, 178, 179 BIA required each participant to refrain from food, drink and 
exercise 2 hours prior to the test and avoid alcohol in the 12 hours prior. Immediately prior to 
commencement, participants were asked to empty their bladder and lay supine on a plinth for 5 
minutes to stabilise body fluids. The participant remained in this position with arms by their sides for 
the duration of the test. The skin was adequately prepared to reduce impedance through excess hair 
removal, fine abrasion tape and alcohol swabs. Pairs of Ag/AgCl electrodes were then applied to the 
right hand and foot between the radial and ulna styloid processes of the wrist and 1cm proximal to 
the metacarpophalangeal joint of the middle finger; and between the medial and lateral malleoli of 
the tibia and fibula, and 1cm proximal to the metatarsophalangeal joint of the middle toe, 
respectively. Each electrode pair was a minimum of 10cm apart. Resistance and reactance was 
recorded from the BIA device and then used to calculate %TBF from the BIA software. 
 
5.2.4.3 Relative abdominal adiposity 
 
Abdominal adiposity was assessed using an Echowave II 2.3.6 LogicScan 128 EXT-1Z Series 
Beamformer ultrasound device involving linear measurements of adipose tissue thickness based on 
anatomical references such as the linear alba,32, 182 and using previously validated and reliable 
methods.32 Prior to US testing, participants were required to lie supine on a plinth for a period of 10 
minutes to allow body fluids to stabilise and conductive gel was used to gain clear images. One 
visceral adiposity and three subcutaneous adiposity measurements were conducted over three 
anatomical locations on the surface of the skin in the trunk region of each participant, of which two 
have been described elsewhere.32 Details of each measurement are shown in Table 5.1 and Figures 
5.1 and 5.2 respectively. The following relative adiposity ratios were calculated from US-derived 
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adiposity thickness measurements: A-L, abdominal-to-lumbar adiposity; A-L/WC, abdominal-to-
lumbar adiposity relative to waist circumference; and TC-TBF, total trunk adiposity circumference 
relative to percentage of total body adiposity. Given the nature of the Sorensen test and parameters 
being explored, such adiposity ratios were considered worthy of inclusion.  
  
Table 5.1 Ultrasound measurements  
Measurement Probe Anatomical location Method used for measurement 
MsAa Linear  2cm above the umbilicus  
Maximum distance in the centre of 
the image between the fat-skin 
barrier and the anterior surface of 
the linea alba 
MiA Convex  
2cm above the umbilicus 
(same anatomical position as 
the maximum subcutaneous 
abdominal adiposity A 
measurement) 
Maximum distance in the centre of 
the image between the posterior 
surface of the rectus abdominis 
muscle and the anterior wall of the 
abdominal aorta 
MsSI Linear 
Just above the iliac crest on 
the mid-axillary line 
Maximum distance between the 
fat-skin barrier and the anterior 
surface of the external oblique 
muscle 
MsL Linear 
Level of L4/L5 directly over the 
lumbar erector spinae muscle 
Maximum distance between the 
fat-skin barrier and the anterior 
surface of the lumbar erector 
spinae muscle 
MsAa, maximum subcutaneous abdominal adiposity; MiA, maximum intra-abdominal 
adiposity; MsSI,  maximum subcutaneous supra-iliac adiposity; MsL, maximum subcutaneous 
lumbar  adiposity 
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5.2.4.4 Pain 
 
Self-reported pain was measured using a VAS. Current levels of cLBP were recorded by the participant 
on a 100mm line, with ‘no pain’ on the left anchor and ‘worst pain imaginable’ on the right anchor.199, 
214 Participants were also asked to verbally rate their current level of lower back pain from one to ten 
prior to, every 20 seconds throughout and immediately after termination of the Sorensen test, using 
a larger VAS placed on the floor directly beneath them for reference. The VAS questionnaire has been 
(i) 
(ii) 
Figure 5.1 Examples of abdominal US measurements. (i) maximum 
subcutaneous abdominal adiposity A. (ii)  maximum intra-abdominal adiposity. 
(iii) (iv) 
Figure 5.2 Examples of supra-iliac and lumbar US measurements. (iii)  maximum 
subcutaneous supra-iliac adiposity. (iv)  maximum subcutaneous lumbar adiposity. 
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previously shown to be a valid and reliable method of measuring self-reported pain in cLBP and other 
pain research.215-218  
 
5.2.4.5 Surface electromyography (sEMG) 
 
Pairs of Ag/AgCl electrodes (Maxensor, MediMax Global, Australia) with a contact diameter of 10mm 
and center-to-center interelectrode distance of 10mm were placed on the surface of the skin, 
overlying the muscle fibres of the right and left lumbar erector spinae longissimus (LES) muscle 
approximately 2cm lateral to the spinous processes of the L4/L5 vertebrae. Electrodes were applied 
to the skin prior to testing and were placed in accordance with SENIAM guidelines via palpation of 
known bony landmarks to ensure consistency among study participants. Skin was carefully prepared 
prior to electrode placement to reduce impedance to below 5Ω, by the removal of excess hair with 
disposable razors, light skin abrasion using fine sandpaper and use of isopropyl alcohol swabs. Raw 
electromyographic (EMG) muscle signals were recorded continuously throughout the Sorensen test, 
using a biological amplifier system (common mode rejection ratio >85dB at 50Hz, input impedance 
200MΩ; Powerlab, AD Instruments, Australia) sampled at 2000Hz with a 16-bit analog to digital 
conversion. An initial fourth-order Bessel filter between 20 and 500Hz was applied to the raw EMG 
signal, with a subsequent digitally-applied band-pass filter between 10 and 500Hz. All collected 
signals were then rectified and smoothed using a root mean square calculation with a 100ms window, 
as used elsewhere.235   
 
5.2.4.6 Median frequency (MF) 
 
MF was measured post-processing from the sEMG muscle signal and was calculated by the point at 
which the area of the power spectral density was divided in half.235 The analysis of MF from EMG 
muscle signals results in an estimation of the electrical conduction properties of the tissues 
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underlying the surface electrodes and is thereby associated with muscle fiber conduction velocity 
changes.235, 236 More specifically, during sustained isometric contractions (ie. Sorensen test) there is 
an approximate linear relation between conduction velocity and power spectral frequencies.236 
Therefore, muscular fatigue can be examined from the relationship between average muscle fiber 
conduction velocity and frequencies of the EMG power spectrum.236 In the current study, the rate of 
decline in MF was measured as changes to the EMG frequency spectrum using a fast Fourier 
transformation algorithm, and assessed at relative time points of each participants’ total Sorensen 
duration time (5% epochs of normalized time points representing each 20% of duration time). 
Average median frequency (L4/L5) per epoch was calculated using the average of right and left 
lumbar erector spinae muscles, with MF slope plotted relative to time (0 to 100) of Sorensen total 
duration. 
 
5.2.4.7 Kinematics (spinal displacement) 
 
Spinal kinematics were assessed using a dual-sensor three-dimensional (3D) motion analysis 
electromagnetic tracking system (Patriot, Polhemus Inc., USA). The Patriot system (6df, 60Hz/sensor, 
<18.5ms latency) involved the use of a transmitter as a reference point for two sensor receivers by 
emitting a magnetic field detected by the two receivers. It allowed for the collection of biomechanical 
data on position and orientation, by simultaneously computing the real-time movement of the two 
sensors through space. Motion tracking included movement in the X (sagittal plane), Y (transverse 
plane) and Z (coronal/frontal plane) rotational axes. The two electromagnetic motion trackers were 
placed on the surface of the skin overlying the T12 and S1 vertebrae. Data collected was digitally 
processed through the PiMgr for Microsoft Windows computer software. Spinal sagittal movement 
was defined as the total spinal displacement in the sagittal plane (X axis, anteroposterior direction) 
relative to the transmitter reference point (sampled prior to Sorensen test commencement).  
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5.2.5 Statistical analysis 
Statistical analysis was performed using SPSS v23 (IBM, USA). Normality testing of all collected 
variables was assessed using a number of methods, including Kolmogorov-Smirnov and Shapiro-Wilk 
tests, in addition to the examination of frequency histograms and values of skewness and kurtosis. 
Results of normality testing indicated some variables were not normally distributed, so a combination 
of parametric and non-parametric methods were used. Correlation analysis was performed to 
examine relationships between Sorensen duration, sagittal movement, MF slope, pain and measures 
of anthropometrics and adiposity. Pearson correlation coefficient was used for parametric variables 
and Spearman’s correlation was used for non-parametric variables. Variables that were significantly 
correlated to Sorensen duration were used as the predictor variables for mediation and regression 
analysis. Collinearity was assessed from the correlation analysis, whereby highly correlated variables 
(r>0.90) were considered collinear and therefore excluded from further analysis. Variables that were 
not found to be correlated with primary predictor variables were not included in the mediation 
analysis.  
 
Mediation was performed with bootstrapping techniques using the custom written macro PROCESS 
(www.processmacro.org), which was downloaded into SPSS. Mediation analysis investigates the 
effect of a causal variable X on a proposed outcome Y through one or more mediating variables M.237 
Simple mediation involves a single intervening variable, whereas multiple mediation analysis occurs 
in the context of simultaneous involvement from multiple variables.237 Bootstrapping involves 
drawing repeated samples (minimum 1000) with replacement from the original sample to 
approximate the sampling distribution of the indirect effect.237, 238 Since this method is based on 
estimation rather than the assumption of normality,237 it is considered more powerful than traditional 
methods such as Baron and Kenny’s239 causal steps approach, the Sobel test and empirical M-test 
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which require more assumptions than bootstrapping.238 For example, the Sobel test assumes 
normality of the sampling distribution of indirect effects, which tend to be asymmetrical.238 
Alternatively, the bootstrap method can be used to make inferences about indirect effects in the 
majority of models,237, 238 with reduced risk of estimation inaccuracy and type I error.238 Furthermore, 
bias-corrected bootstrapping has been recommended in multiple mediation contexts,237 which is a 
known limitation of the causal steps approach.240  
 
The following a priori conditions had to be successfully met to confirm mediation: 1) X variable 
(independent variable) was significantly associated with Y variable (dependent variable) (total effect; 
c path, Figure 5.3); 2) X variable was significantly associated with one or more proposed mediator 
variables (M) (a paths, Figure 5.4); 3) each of the proposed mediators was significantly associated 
with Y (b paths); and 4) the relationship between X and Y variable was reduced (direct effect, c’ path) 
when controlling for the proposed mediators (indirect effect, a x b), with the 95% confidence interval 
for the indirect effect of each proposed mediating variable outside 0. 
    
 
 
 
 
 
  
c path 
Y X 
Figure 5.3 Total effect of X 
variable on Y variable (c path) 
c’ path 
X 
a path 
Y 
b path 
Figure 5.4 Direct (c’ path) and indirect effects 
(a x b path) of X variable on Y variable when 
controlling for M variable 
M 
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Four mediation models were performed (PROCESS, model 4) to examine whether the proposed 
mediators (pain change, sagittal movement) influenced the relationship between anthropometric 
and adiposity variables (weight, BMI, WC, TC-TBF) with Sorensen duration. Statistical significance 
was set at p<0.05. 
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5.3 Results 
 
Correlation analyses showed that Sorensen duration was associated with weight, BMI, WC, WHR and 
TC-TBF (Table 5.2). No significant associations were observed between Sorensen duration and A-L, 
MF slope or sagittal movement. MF slope was not related to the Sorensen or any anthropometric or 
adiposity variables. A-L was found to be correlated with End pain (r=0.388, p=0.004) and Pain change 
(r=0.342, p=0.013).  
 
Mediation models were performed for weight, BMI, WC and TC-TBF, with respect to Sorensen time. 
No mediation analysis was performed for WHR since not all required criteria were met. The total 
effect (c path) of all four models was statistically significant: weight (B=-1.570, r=0.371, p<0.001), BMI 
(B=-4.319, r=0.307, p<0.001), WC (B=-1.785, r=0.319, p<0.001) and TC-TBF (B=-34.040, r=0.159, 
p=0.005). Weight, BMI, WC and TC-TBF were significantly associated with end pain and pain change, 
but end pain was excluded due to high collinearity (r=0.836, p<0.001). TC-TBF was also associated 
with sagittal movement (Table 5.2). Neither of the proposed mediators (pain change, sagittal 
movement) were significantly associated with Sorensen time. Since only two of the four required 
steps to confirm mediation were met, no further analysis was performed. 
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Table 5.2 Correlations between task performance (Sorensen) with anthropometric, spinal movement, pain and muscle 
endurance outcomes 
 1 2 3 4 5 6 7 8 9 10 
1. Sorensen -          
2. Weight -.542ꝉ** -         
3. BMI -.453 ꝉ** .818 ꝉ** -        
4. WC -.478 ꝉ** .847 ꝉ** .876 ꝉ** -       
5. WHR -.519 ^** .558 ꝉ** .470 ꝉ** .704 ꝉ** -      
6. TC-TBF -.370^** .211 ꝉ .171 ꝉ .251 ꝉ .063^ -     
7. Sagittal .197 ꝉ -.163 ꝉ .019 ꝉ -.101 ꝉ -.144 ꝉ -.334 ꝉ* -    
8. End Px .181^ -.361 ꝉ** -.320 ꝉ* -.335 ꝉ* -.148^ -.434^** .035 ꝉ -   
9. Px Change .269^ -.424 ꝉ** -.359 ꝉ** -.419 ꝉ** -.225^ -.415^** .167 ꝉ .836^** -  
10. MF slope -.148^ -.074 ꝉ -.202 ꝉ -.071 ꝉ -.015^ .120^ -.059 ꝉ -.164^ -.169^ - 
BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; TC-TBF, total circumference relative to total body 
adiposity ratio; Sagittal, spinal movement in the sagittal plane; End Px, self-reported pain at test cessation; Px Change, 
change in self-reported pain from start to test cessation; MF slope, rate of decline in median frequency as indicator of 
lumbar muscle endurance  
ꝉ Spearman’s rho 
^Pearson Correlation 
**Correlation significant at p<0.01 level 
*Correlation significant at p<0.05 level 
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5.4 Discussion 
 
The main findings of this study showed that Sorensen duration was associated with weight, BMI, WC, 
WHR and TC-TBF, but not A-L, MF slope or sagittal movement. Based on these findings, the hypothesis 
that increased body mass and its distribution would be related to poorer Sorensen task performance 
was supported. Similar to previous research,211 significant correlations were identified between A-L 
and self-reported pain, but particularly the pain experienced at test cessation. Changes in task-
induced pain were also found to be moderately correlated with weight, BMI, WC and TC-TBF. Results 
of the mediation analysis indicated strong relationships between Sorensen duration and predictor 
variables (weight, BMI, WC, TC-TBF), but mediator variables (pain change, sagittal movement) had 
minimal influence on the models. Therefore, the relationship identified between body mass 
distribution and Sorensen duration was not explained by increased spinal flexion or faster rates of 
muscle fatigue as hypothesised. 
 
The link between A-L and end pain but not task duration, may suggest that increasing abdominal 
adipose tissue is associated with greater task-induced pain development. In addition, the moderate 
correlations observed between pain change and measurements of body mass, body composition and 
adiposity distribution may indicate that pain is a common denominator among such measurements 
in cLBP populations. Since body mass measures contributed to Sorensen duration but A-L did not 
(despite associations with pain), it may indicate that the restricted nature of the task to a specific 
position prevented the manifestation of an A-L effect. For instance, within the context of the testing 
procedure, individuals were required to maintain an isometric horizontal position with the upper 
body unsupported and arms folded across the chest. Each participant was prompted when necessary 
to correct their posture, such as by lifting their head and shoulders back up to the starting position. 
If they weren’t able to amend their position within five consecutive seconds the test was terminated. 
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By restricting the within-test variation in this manner, it may have reduced the capacity of the test to 
exhibit an effect of A-L disparity on test duration. For example, limiting the degree of upper body 
movement, possibly altered the natural posture that individuals may have otherwise adopted. The 
test was controlled to this extent to ensure validity and comparability of the results, but in doing so 
may have also concealed differences in A-L effects on posture throughout the task.  
 
Moreover, TC-TBF was found to be related to Sorensen duration, although the relationship was 
weaker than more simplistic body mass measures. Since TC-TBF refers to subcutaneous adiposity of 
the mid-section proportional to total body adiposity, it may indicate relative adiposity distribution in 
a similar but less specific manner to the A-L. Of all predictor variables measured, sagittal movement 
was only found to be correlated with TC-TBF. This may be due to its specificity as an adiposity 
measurement, whereby increased central adipose tissue places greater demand on the spine and 
leads to acute spinal flexion and faster muscle fatigue. Conversely, sagittal movement was not related 
to WHR, despite the significant correlation between WHR and Sorensen duration. Therefore, perhaps 
there is a common element underpinning a relationship between spinal movement and trunk 
adiposity distribution, but not overall trunk mass. Another possibility may be that in individuals with 
higher A-Ls, they are in a prolonged state of increased lumbar flexion or spinal hyperlordosis from the 
excess anterior adipose tissue. The concurrent risks accompanying such a state have been well-
documented in the past. For example, a flexed posture has been shown to reduce the capacity of the 
spine to tolerate shear forces,164 and the yield point of spinal compressive loading is reduced with a 
flexed failure posture.165 As a result, it has been stated that the amalgamation of both prior loading 
history and a flexion-based posture alters the compressive strength and mode of failure of the 
spine.165 If a chronic state of increased spinal lordosis was present in cLBP sufferers with higher 
anterior to posterior loading ratios, it may infer a pre-task discrepancy of spinal positioning between 
those with higher compared to lower A-Ls. Since the degree of spinal flexion was not measured prior 
to the test (separate to the reference position), it is difficult to confirm or refute this possibility. 
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However, it may support the need for further research in this area, particularly if an A-L effect may 
have been observed if the task was not controlled so diligently. 
 
The identified relationships between mass measurements (weight, BMI, WC) and Sorensen time were 
of moderate strength and negative direction, indicating that less favourable body composition or 
body mass resulted in poorer task performance. It is plausible for this result to be attributed to the 
degree of loading of the test. For example, previous research has shown that the Sorensen test 
performed at 100% of the head-arms-trunk (HAT) segment is not a sufficient load to reveal 
differences between people with and without LBP symptoms.226 Furthermore, this has been observed 
despite decreasing endurance times for increasing HAT segment loading.226 Although 100% HAT 
loading has previously showed no differences between people with LBP and those without, segmental 
loading at 160% HAT was found to reduce task duration by 40% among those with LBP.226 The 
population tested was not cLBP-specific, but such findings may still be of relevance. For example, it is 
possible that the 100% HAT loading used for the Sorensen test in the current study was not adequate 
to reveal a true pain mediation. Moreover, this segmental loading consideration may also play a role 
in the apparent lack of effect of A-L on Sorensen duration. It may be reasonable to believe that had 
the HAT loading been increased above 100%, negative consequences of larger A-Ls on task 
performance may have been observed.  
 
Although this study’s findings have demonstrated that mass may impact task performance in people 
with cLBP, it remains unknown why they perform more poorly in the Sorensen test. Since both spinal 
flexion and rate of MF decline were not related to or predictors of test duration, the results of the 
current study did not fully explain Sorensen performance. In addition to HAT loading considerations, 
it is possible that the test itself may have produced an inadequate representation of muscle fatigue. 
For example, it has previously been argued that increases in hip extensor activity and other 
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alternative strategies of load-sharing may prolong test duration, and therefore provide an inaccurate 
reflection of lumbar muscle endurance.226 Moreover, LBP sufferers may exhibit higher resistance to 
fatigue, by employing altered physiologically-coordinated muscle strategies to compensate for a 
lower level of lumbar muscle endurance.226 An alternative suggestion is that pain augmentation may 
be an indirect result of increased body mass parameters, or the consequence of adiposity 
distribution. Assuming this was the case, perhaps such effects were simply not revealed in the context 
of the postural task tested. It was reasonable to believe that greater abdominal adiposity may 
provoke flexion-induced LBP symptoms and muscle fatigue in a postural task, but it was not 
confirmed in the current study. However, it does not necessarily conclude that such an effect would 
also fail to be seen in different experimental contexts. 
 
Although no earlier studies have explored the effect of relative adiposity distribution on the Sorensen 
test, body mass indices have been included in the past. Such measurements have consisted of body 
weight,241, 242 %TBF,243 BMI and the Davenport index,234, 244 yet these studies have produced 
inconclusive results. For example, two studies have used BMI and the Davenport index, one involving 
adult men and women with cLBP244 and the other healthy men and women.234 In the cLBP study, there 
were no differences identified in muscle endurance between obese and non-obese individuals.244 
Irrespective of the disparity in outcome measures used, the results of the current study indicated a 
similar finding of no relationship between A-L and lumbar muscle endurance in cLBP. Alternatively, 
researchers in the second study on healthy men and women observed an inverse relationship 
between BMI and paraspinal muscle fatigue, which was more apparent at the L4/L5 than L1/L2 
level.234 Moreover, differences have also been found among earlier studies involving body weight.241, 
242 For instance, one study identified reductions in static lumbar endurance time with increasing 
weight,241 yet another found no significant correlation between body weight and endurance242 
despite assessing comparable population samples. Furthermore, %TBF has also been shown to 
contribute to static lumbar muscle endurance time,243 although the presence or absence of pain in 
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the study population was not classified. Such inconsistency among research studies makes it difficult 
to draw conclusions regarding the effect of body mass parameters on the Sorensen test. However, 
these previous findings may support the notion of increased anterior force on the lumbar spine 
coinciding with larger A-Ls, and potentially greater lumbar muscle fatigue to compensate these 
forces. It is possible that the discrepancy among research may be explained by the inclusion of pain 
change in the mediation models of the present study. For example, perhaps there is an underlying 
mechanism of pain interference with the observation of an abdominal loading-fatigue interaction, 
which is otherwise shown in healthy populations. For this reason, it may be necessary to further 
compare healthy and cLBP populations performing the Sorensen test, to better understand potential 
influences of adiposity and body mass measures on muscle endurance and task duration. 
Furthermore, the potential influence of psychological factors on task performance cannot be ruled 
out. In a previous Sorensen study, negative beliefs about back pain and greater psychological 
disturbance (combined somatic symptoms and self-rated depression) were predictors of 
underperformance among those with cLBP. It was observed that 22% of the variance in expected 
versus actual task duration was explained by such psychological factors.229 
 
The novel aspect of this study lends itself to potential constraints. For example, the findings may 
reflect the possibility that the current nature of the Sorensen task did not permit an A-L effect to be 
fully manifest. Moreover, there is existing debate within the literature regarding the validity and 
relevance of the MF method for the assessment of muscular fatigue.223, 245 This may suggest that MF 
was not the most appropriate method to use for the present study, regardless of its common use in 
Sorensen test research.223, 226, 231, 234, 245 Therefore, the finding that MF slope was not related to 
Sorensen duration or anthropometric and adiposity measurements may suggest that body mass has 
no impact on lumbar muscle fatigue. However, it cannot be concluded that this result would be 
replicated with the use of an alternative fatigue method. Regardless of such methodological 
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considerations, study findings imply that upper or total body mass and its relationship to pain may 
play a role in the Sorensen test.   
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5.5 Conclusion 
 
Further research is needed to support or refute the findings of the present study and continue to 
investigate the complex relationship between obesity and cLBP. More specifically, future studies 
should look to explore anthropometric and adiposity variables in other postural tasks, and perhaps in 
comparison between cLBP and healthy populations. The results of this study have added to previous 
research findings, through the confirmation of a relationship between body composition and 
distribution with self-reported pain in cLBP sufferers. The evidence suggests that there may be an 
interaction between spinal positioning, mass distribution and pain that should continue to be 
explored in the future.  
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Chapter 6: General Discussion and Conclusion 
 
6.1 Summary and Interpretation of Main Research Findings  
 
The aim of this thesis was to investigate the relationship between obesity and cLBP, and explore 
possible factors mediating that relationship. The primary research findings support the hypothesized 
association between abdominal adiposity and pain, but not disability, among people with cLBP. 
Although body mass distribution negatively affected task performance in cLBP individuals, abdominal 
adiposity was not related to performance for the task employed. The hypothesis that spinal 
movement and lumbar muscle fatigue would mediate obesity and cLBP during postural performance 
was not supported.   
 
Past research has provided evidence of a relationship between obesity and cLBP,23, 71-80 with common 
findings linking BMI and cLBP,23, 73, 74, 78, 81 or general LBP.68, 77, 142 Although there was heavy reliance 
on BMI in previous LBP research,71, 74, 76, 78, 139 limitations of the measure were raised.73, 80 Such 
research also highlighted several inconsistencies, including poor BMI classification regarding cutoff 
points and unclear delineation between overweight and obesity categories.97 Earlier conclusions 
indicated a lack of definitive evidence to link BMI-based obesity with LBP.77 The results of Study 1 of 
this thesis provide clarification and understanding of earlier research findings. For example, since no 
relationships with BMI and pain or disability (including changes) were observed, it is evident that BMI 
should not be relied on as the sole outcome measure of obesity in cLBP research. Alternatively, it has 
been proposed that adiposopathy needs to occur in combination with an elevated BMI for 
musculoskeletal pain to be experienced.152 For instance, adipocyte immune cells in an adiposopathic 
state may act similarly to bacterial infection or autoimmune disease.152 However, adiposity may not 
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always result in chronic inflammation.152 This notion may explain the lack of consistent correlation 
between increased BMI and LBP symptoms, particularly if chronic systemic inflammation induced by 
changes to adipocyte metabolic activity only takes place in certain individuals.152 
 
The findings of Study 2 support the need for greater consideration of adipose tissue and its 
distribution in the obesity-cLBP relationship, rather than focusing on simplistic anthropometrics. 
Adipose tissue distribution has been implicated in the past, since it was found to be more closely 
related to risk of cLBP than BMI.112 Although not of a chronic nature, associations between obesity 
and LBP have been shown in the upper percentages of BMI only,142 presumably indicating greater 
adiposity since adipocyte size increases with rising BMI.152 It is known that cLBP prevalence escalates 
with increasing WC, WHR and BMI,73 and the results of Study 2 showed that self-reported pain was 
associated with adiposity distribution. Such findings may help explain the stronger BMI-LBP 
associations with higher BMI percentages observed in the past. Moreover, Study 2 showed that 
relative abdominal-to-lumbar adiposity (A-L, A-L/WHR, A-L/BMI) was associated with cLBP, which 
may support the integral role of adipose tissue in obesity-cLBP pathophysiology. Recent research has 
also reported relationships between adiposity and pain.149-151 For example, fat mass and the fat mass 
index (FMI; DXA-derived fat mass / height2) as well as traditional body weight and BMI, have been 
significantly associated with increased risk of multisite pain, pain at weight-bearing body sites, hand 
pain and pain at a greater number of lower body sites.149, 151  
 
Although the novel findings of Study 2 indicated that abdominal adiposity distribution relative to 
trunk or total body size is important in the obesity-cLBP relationship, explanations for such 
associations were still unclear. Early research into obesity and LBP had concluded it was unknown if 
the relationship was causal.14, 75, 77 Other studies proposed the obesity-pain relationship may be 
mediated by multiple interrelated factors.67, 70 The possibility of a bi-directional link between obesity 
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and pain was also suggested,116 or that obesity may be a marker for a true causal factor.72 For this 
reason, Study 3 was an exploration of such possibilities, within the context of a gravity-counteracting 
postural task of the Sorensen test. The findings indicated that body mass and its distribution were 
linked to poor Sorensen performance, and supported the correlation between A-L and cLBP observed 
in Study 2. In Study 3, weight, BMI, WC and TC-TBF were also associated with pain change throughout 
the test, although mediation of such variables was not confirmed. Moreover, the relationship 
between body mass distribution and test performance was not explained by spinal movement or 
lumbar muscle fatigue. Therefore, it is possible that there may be two different mechanisms of action 
involved. For example, perhaps the A-L correlation to cLBP may indicate a metabolic mediation, 
whereas the anthropometric variables may suggest more of a mechanical role. Such suggestions have 
also been recently raised in research on body composition and multisite pain. Two separate studies 
proposed metabolic factors were implicated in multisite pain pathogenesis.149, 151 Fat mass or body 
weight was said to play an important part, with a systemic role likely due to the association between 
fat mass and hand pain, which is not a weight-bearing site.151 This was supported by the second study, 
in which the same association to pain at lower body sites was not observed for fat-free mass.149 
However, a possible biomechanical loading effect was also suggested, since fat mass, FMI and BMI 
were linked to pain at all weight-bearing sites.151 Consequently, it may be possible for the findings of 
Study 3 to be corroborated should similar research be conducted in the future. Although mediation 
possibilities including contributions of spinal movement and adiposity distribution to mechanical 
loading in the obesity-cLBP relationship were not identified, they may still be of relevance. 
Furthermore, this finding does not rule out the possibility of observing an A-L effect in a different 
postural task or testing situation. In either instance, Study 3 confirmed a connection between body 
composition and cLBP.  
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The importance of abdominal adiposity and body mass distribution on cLBP identified in this thesis 
has been supported by the possibility that obesity-induced mechanical loading of the lower back 
region may be dependent on body morphology, or somatotype.147 For example, a recent study on 
body segment inertial parameters observed increases in both trunk moments of inertia and radii of 
gyration.147 It was suggested that central adiposity is likely to have negative implications for spinal 
loading, on the basis of increased trunk moments of inertia and injury risk through near-maximal 
torque estimates.147 The authors further raised the probability of earlier onset of neuromuscular 
fatigue in repetitive tasks, and substantial cumulative impacts during walking and carrying over the 
long-term.147 Therefore, it is reasonable to believe that back pain may be the net result, particularly 
when occurring for prolonged periods of time. For example, this may be the case for central adiposity-
obese individuals, or those with an increased A-L. Abdominal adiposity accumulation may also result 
in greater daily mechanical loading of the lumbar spine through compressive and shear forces, since 
increased abdominal and sagittal diameters have been associated with greater odds of severe lumbar 
disc degeneration.148 
 
Evidently, there is still controversy among obesity-LBP research. For example, authors of a recent 
study on various anthropometric measures and LBP, suggested central adiposity doesn’t explain LBP 
occurrence.246 This was due to the finding that all body size measures (body weight, BMI, WC, WHR, 
hip circumference) were significantly related to LBP risk in both genders, after age adjustment.246 
They also found that significant associations between WHR and LBP were greatly reduced after 
adjustment for other risk factors.246 Since the results of this thesis suggest A-L relative to WHR or BMI 
were the strongest predictors of cLBP, the adiposity to size ratio may be paramount. Alternatively, 
perhaps the primary issue is the sole usage of fat mass measurements or simplistic body size 
measurements, such as WHR, BMI or WC. Fat mass to muscle mass ratio may also warrant 
consideration, since high fat mass-to-muscle ratios have been recently linked to increased 
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musculoskeletal pain.247 As a result, research on obesity and cLBP may require a more holistic and 
comprehensive consideration of body composition, relative to body size and shape. The importance 
of body composition may allude to a series of interrelated factors that lead to the pain expression 
underpinning several musculoskeletal pain pathologies. Perhaps it is not the separation of mechanical 
or inflammatory mediation possibilities that is most important, but rather the consideration of 
potentially intertwined variables that is of significance. For example, adiposity-induced chronic low-
grade inflammation is a known contributor to atherosclerosis, which has been linked to disc 
degeneration.148 Such deliberations also originate from the assumption that all cases of cLBP or LBP 
are pathologically identical, which is unlikely given the physiological complexity of the human body 
and vast opportunity for biological variation. Therefore, there may not be one simple explanation, 
cause or mediation that encapsulates the overall obesity-cLBP relationship.  
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6.2 Limitations of the Research 
 
The conflicting nature of previous research into obesity and cLBP or related parameters (LBP, BMI, 
body weight) lends itself to careful consideration of study limitations. One potential constraint is the 
exercise program in Study 1 was based on cLBP treatment and not BMI modification. A program 
tailored towards body mass manipulation with monitoring of inflammatory blood markers may have 
shed more light on the results, providing a firmer conclusion of evidence and increased understanding 
of previous findings. Such mass manipulation and inflammation studies relating to Study 2 may have 
also been beneficial. However, previous research had relied on the BMI measurement, provided 
inconclusive evidence between obesity and LBP, and lacked thorough exploration of adiposity and 
pain linkages. Therefore, it was believed to be more important to first examine BMI in the context of 
common exercise-based cLBP treatment, and establish baseline relationships between adiposity and 
cLBP. 
 
Another limitation of Study 2 was the subjective nature of US methodologies. Since each image must 
be individually measured by the researcher, bias or intra-rater error is a possibility. Potential bias may 
have been reduced by including a comparison to CT or DXA, but such methods are expensive and 
would have rendered US unnecessary. Moreover, US is an established valid and reliable method of 
assessing abdominal adiposity compared to gold standard methods.32, 90, 182-184, 186 Lastly, only one 
postural task was employed in Study 3, with no specific gender or non-cLBP comparison included. As 
neither gender or non-cLBP populations were the focus of this thesis, it was a constraint considered 
to be outweighed by the primary aim of the research.  
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6.3 Thesis Research Output  
 
Two scientific journal articles197, 211 have been produced as a result of the research conducted in this 
thesis, and have been published in internationally known peer-reviewed journals. Spine has an impact 
factor of 2.439 (Journal Citation Reports, JCR; 2015) and a 5-year impact factor of 2.786 (JCR, 2015). 
BMC Public Health is an open-access journal with an impact factor of 2.209 (JCR, 2015) and a 5-year 
impact factor of 2.746 (JCR, 2015). The two published journal articles197, 211 resulting from this thesis 
have been cited 8 times, as at 9 May 2017. Therefore, the work of this thesis is of publication quality 
with important contributions to research and clinical contexts. 
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6.4 Research and Clinical Implications 
 
The value of this work is two-fold, as it contributes to both obesity and cLBP research fields. Despite 
the precise etiology and interaction remaining unknown for obesity and cLBP as well as other related 
conditions, it is clear that they are no longer separate entities. As described earlier in this thesis, the 
majority of previous research focused on general LBP using BMI as a single obesity measurement. 
Consequently, some studies may need to be repeated in the context of cLBP populations, with the 
inclusion of multiple obesity measures to assess body size and composition. It is evident that a large 
scope of research remains to be explored regarding linkages between obesity and cLBP. For example, 
consideration of a possible inflammatory pathway within the obesity-cLBP relationship may be 
examined through exercise or nutrition-based intervention studies, with a focus on manipulation of 
body mass or body composition. Other research possibilities may include neuromuscular 
consideration in integrated obesity-cLBP studies, thresholds of central adiposity and their effect on 
pain, the biomechanics of an obese state, adiposopathy and metaflammation interactions with pain 
manifestation, and potential linkages to other musculoskeletal pain conditions. Regardless of the vast 
research potential remaining in this area, the work of this thesis is innovative and novel. Relationships 
between BMI and exercise-induced cLBP changes had not been previously explored, and past studies 
had lacked consideration for possible associations between adiposity distribution and cLBP. 
Moreover, the notion of mass distribution and mechanistic mediation during a postural task in the 
obesity-cLBP relationship had not been previously examined.    
 
The research resulting from this thesis also has clinical implications through evidence-based 
treatment recommendations for practitioners. For example, it is reasonable to believe that the 
treatment approach of obese individuals and cLBP sufferers should be reflective of the established 
association between the two conditions. Such considerations may include exercise prescription 
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tailored towards the reduction of abdominal adipose tissue, or the attainment of a more favourable 
body composition. These possibilities may not necessarily instigate direct changes to obesity or cLBP 
treatments, but rather promote a more holistic approach to the prescribed treatment. Instead of 
practitioners treating obesity and cLBP as separate health problems, they may consider them as an 
interrelated condition of sub-optimal wellbeing. In doing so, the work of this thesis may help to 
improve clinical treatment efficacy. 
 
  
124 
 
6.5 Overall Concluding Remarks  
 
This thesis has indicated that obesity and cLBP are related conditions. Study 1 showed that BMI may 
not be the most appropriate obesity measure to use for cLBP research, particularly in isolation. Study 
2 and Study 3 have indicated that adiposity and its distribution around the body is important for cLBP, 
particularly when considered relative to overall body size and shape. Although no mediation between 
A-L, lumbar muscle endurance or sagittal spinal movement with Sorensen task performance was 
identified for the obesity-cLBP relationship, it does not rule out the possibility of effects being 
observed in alternative research contexts. It is evident from the work of this thesis that consideration 
of adipose tissue and its distribution may be paramount in chronic pain pathologies. A large scope of 
research still remains to be explored, but this research has contributed to the body of evidence linking 
obesity with cLBP. This thesis has demonstrated the importance of the work within the obesity and 
cLBP fields. Two journal publications have been produced and there is clearly a growing interest in 
this research area among the scientific community. The work of this thesis provides a strong 
foundation to an extremely relevant issue. 
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